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RESUMO 
Esta pesquisa teve como objetivo o desenvolvimento tecnológico de processo 
microfluídico para a obtenção de vetores não virais, baseados na complexação 
eletrostática entre lipossomas catiônicos (LC) e DNA plasmideal (pDNA) destinados à 
terapia e vacinação gênica. O desenvolvimento desse processo foi comparado ao 
processo convencional “bulk”, que, a partir da simples mistura manual entre as 
soluções ou em sistema de vórtice, gera dificuldade no controle do tamanho destas 
estruturas e pode produzir variações nos resultados biológicos e na estabilidade 
coloidal. Já o processo microfluídico, que utiliza dispositivos que processam pequenas 
quantidades de fluidos (10
-9
 a 10
-18
 litros), permite a complexação eletrostática em 
regime contínuo, com o controle das condições difusionais, o que também permite 
melhor controle do tamanho destes complexos. Metodologicamente, o trabalho foi 
dividido em três principais etapas: na primeira parte, foi realizado o estudo físico-
químico, estrutural e biológico dos complexos pDNA/LC obtidos por processo “bulk”. 
Nessa etapa, verificou-se a correlação das propriedades físico-químicas e estruturais 
dos complexos com o processo de transfecção in vitro em células HeLa. A segunda 
parte do trabalho visou à otimização da produção de lipossomas catiônicos em dois 
dispositivos microfluídicos, com uma única e com dupla focalização hidrodinâmica, de 
modo a se obter lipossomas similares aos estudados na primeira parte do trabalho. 
Na utilização do segundo dispositivo, foi possível operar em vazões volumétricas mais 
altas quando comparadas ao primeiro. Por fim, na terceira parte, foi realizado o estudo 
da complexação entre LC e pDNA por processo microfluídico também em dois 
diferentes dispositivos, um similar ao utilizado na segunda parte do trabalho, com 
focalização hidrodinâmica única, e outro com blocos regulares nas paredes do 
microcanal, o que aumenta a área de contato entre os fluidos. Os complexos 
formados no primeiro dispositivo apresentaram melhores respostas biológicas in vitro, 
as quais foram similares às do processo “bulk”. No segundo dispositivo, ensaios de 
acessibilidade de sonda de fluorescencência ao DNA indicaram alteração na 
associação entre LC e DNA. Dessa forma, a partir dos resultados, conclui-se que os 
dispositivos microfluídicos estudados são uma alternativa promissora para a formação 
de LC e também sua complexão com pDNA em modo contínuo, tanto pela 
potencialidade tecnológica quanto biológica, o que contribui para o desenvolvimento 
de produtos farmacêuticos que veiculam DNA e que são destinados à terapia e 
vacinação gênica. 
Palavras chave: Lipossomas; Transfecção; Microfluídica; Nanotecnologia. 
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ABSTRACT 
This research aimed at the technological development of microfluidic process for 
nonviral carriers production based on the electrostatic complexation between cationic 
liposomes (CL) and plasmidal DNA (pDNA) for gene and vaccine therapy applications. 
The development of this process was compared to the conventional bulk process, in 
which the solutions are mixed followed by the simple hand shaking or brief vortexing, 
what generates difficulties on the particles sizes control and can affect the biological 
functionality and colloidal stability of the formulations. In contrast, microfluidic process, 
which uses devices that manipulate small amounts of fluids (10
-9
 to 10
-18
 liters), allows 
the electrostatic complexation in continuous mode, controlling diffusion conditions, 
which also allows the colloidal control of the obtained formulations. Furthermore, 
microfluidic devices have minimum dimensions and operate with low energy 
consumption. Methodologically, the present work was carried out in three mean steps: 
in the first step, the physicochemical, structural and biological characteristics of the 
pDNA/CL complexes obtained by the bulk process were studied. In this step, it was 
possible to verify the correlation of physicochemical and structural properties with the 
transfection phenomenon in vitro of HeLa cells. The second part of this work focused 
the optimization of the production of CL through two microfluidic devices, with single 
and double hydrodynamic focusing, to obtain similar CL to those of the first step of this 
work. By employing the second device, it was possible to operate at higher volumetric 
flow rates than the first one. Finally, in the third step, it was explored the complexation 
between CL and pDNA via microfluidic process also in two different microfluidic 
devices; the first was similar to that employed in the second part of this work, with a 
single hydrodynamic focusing, and a second one with patterned microchannel walls, 
which increase the surface contact area between the fluids. The complexes formed in 
the first device showed better biological results in vitro, which were similar to the 
complexes formed in the bulk complexation method. In the patterned device, the 
experiments of the DNA accessibility to fluorescent probe pointed out modifications 
between the pDNA and CL association in the complexes. In conclusion, we showed 
that the studied microfluidic devices are a promising alternative for the production of 
CL and the complexation with pDNA in continuous mode, because of the technological 
and biological potentialities, which contributes to the development of feasible 
processes, for the production of new pharmaceutical products for gene and vaccine 
therapies. 
Keywords: Liposomes; Transfection; Microfluidics; Nanotechnology.  
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____________________________________________________________________ 
CAPÍTULO 1 – INTRODUÇÃO GERAL 
____________________________________________________________________ 
 
1. Introdução 
 A terapia gênica é uma técnica promissora destinada à terapia preventiva e 
ao tratamento de inúmeras doenças, baseada na introdução de material genético 
em células específicas (CORSI et al., 2003). Visa a correção dos genes 
responsáveis por uma determinada doença ou a produção de determinada 
proteína pela própria célula. Esta terapia pode ser utilizada em diversos tipos de 
doenças, tais como câncer, AIDS e doenças cardiovasculares (TURAN et al. 
2003). A partir da década de 90, este conceito foi também estendido à profilaxia e 
tratamento de doenças infecciosas, tais como a tuberculose (Rosada et al. 2008 e 
TORRE et al., 2009) e Leischmaniose (GOMES et al., 2007).  
 Uma grande dificuldade na utilização deste material genético em aplicações 
in vitro e in vivo é que o DNA é quimicamente instável quando em contato com 
vários componentes corpóreos e, considerando sua natureza química (carga 
negativa) e seu tamanho elevado, o processo de transfecção (entrada nas células 
e no núcleo) é dificultado (LASIC, 1997, ROPERT, 1999). 
 Nesse sentido, os efeitos de veiculadores têm sido investigados por vários 
grupos de pesquisa, a fim de se obter proteção para o DNA em contato com os 
fluidos corpóreos/extracelulares e aumentar sua eficiência de transfecção in vitro e 
in vivo. Dentre os vetores não virais para entrega de material genético, os 
Lipossomas Catiônicos (LC) se apresentam promissores, pois permitem a 
proteção do DNA e o acoplamento, na sua superfície, de compostos que 
aumentam a eficiência de transfecção. Além disso, a facilidade de interação com 
as células é uma característica intrínseca dessas estruturas lipídicas, devido à sua 
semelhança com a membrana celular (LABAS et al., 2010, DE ROSA & LA 
ROTONDA, 2009). 
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 Lipossomas são estruturas aproximadamente esféricas de dimensões 
coloidais com cerne aquoso circundado por uma ou mais bicamadas lamelares 
lipídicas. São formados principalmente por fosfolipídios que se auto-agregam 
espontaneamente em vesículas em meio aquoso, incorporando parte desse meio 
em que se encontram.  
 Apesar da grande quantidade de estudos na área e de demonstrar sucesso 
em suas aplicações, o número de produtos lipossomais aprovados em aplicação 
humana é pequeno. Dentre outras razões, isso se deve ao fato de não haver 
métodos de produção de lipossomas eficientes de baixo-custo. Em muitos dos 
métodos, a auto-agregação não é completamente controlada, levando à 
necessidade de utilização de operações unitárias subsequentes para a redução do 
tamanho (MOZAFARI, 2005). Assim, a produção desses vetores em larga escala 
nas condições requeridas para sua aplicação é uma etapa limitante das 
formulações lipossomais destinadas à terapia e à vacinação gênica. Para isto, 
fazem-se necessários estudos de processos capazes de reproduzirem as 
propriedades físico-químicas e biológicas dos lipossomas funcionais, 
anteriormente obtidos por processos laboratoriais, sem alterar a estabilidade 
coloidal dos mesmos. 
 Uma alternativa para contornar estas dificuldades de processo é a 
realização da produção de LC e sua complexação eletrostática com DNA em 
sistemas microfluídicos, permitindo um melhor controle dos processos difusionais 
e, consequentemente, melhorando o controle do tamanho e polidispersidade das 
partículas e sua estabilidade. Além disso, os sistemas microfluídicos possuem 
tamanho mínimo e operam com baixo consumo de energia. 
 Essa perspectiva, chamada de Intensificação de Processo, tem recebido 
muita atenção na Engenharia Química moderna. Ela concerne a inovações que 
reduzem o tamanho da planta e consumo de energia em várias ordens de 
grandeza para um determinado objetivo e consiste no desenvolvimento de novas 
tecnologias que tragam melhorias na produção e processamento. Essas 
inovações diminuem substancialmente a razão tamanho de 
equipamento/capacidade de produção e são mais eficientes energeticamente, 
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resultando em tecnologias sustentáveis de menor custo (STANKIEWICZ et al., 
2009; SPOORTHI et al., 2010). Neste contexto, a microfluídica se apresenta como 
uma forma de alcançar a intensificação de processo, integrando, em uma única 
etapa, determinados processos e etapas subsequentes de produção. 
 No cerne dessa perspectiva de desenvolvimento de processos 
microfluídicos, esse trabalho visa a contribuir para o desenvolvimento de novos 
processos de obtenção de vetores não virais baseados em LC, destinados à 
terapia e à vacinação gênica utilizando a microfluídica como estratégia para o 
controle na formação dos lipossomas e seus complexos com DNA. 
 Em última instância, esse trabalho contribuirá para o desenvolvimento 
tecnológico de novos processos que viabilizem produtos farmacêuticos que 
veiculem DNA destinados à terapia e vacinação gênica. 
2. Objetivos  
O objetivo deste trabalho foi o de contribuir na área da nanobiotecnologia, 
mais especificamente para o desenvolvimento de novos processos de obtenção 
de vetores não virais baseados em lipossomas catiônicos destinados à terapia e 
vacinação gênica. Para tal, a partir de LC obtidos por processo microfluídico, 
estudou-se o processo de complexação eletrostática entre LC e DNA, em sistema 
microfluídico, empregando dispositivos de focalização hidrodinâmica e comparou-
os ao processo de complexação convencional “bulk”.  
A pesquisa foi estruturada a partir dos três principais objetivos: 
 Caracterização dos complexos DNA/lipossomas catiônicos obtidos pelo 
método convencional “bulk”: determinação das condições de complexação 
“bulk” entre LC e DNA que foram utilizadas como referência para o 
desenvolvimento do processo microfluídico. 
 Estudo do processo microfluídico para a produção de lipossomas catiônicos: 
produção de LC através de dispositivos microfluídicos de focalização 
hidrodinâmica (simples e dupla) em maiores concentrações lipídicas, a fim de 
produzir essas nanopartículas com níveis de polidispersidade e tamanho 
similares aos LC produzidos pelo método “bulk”. 
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 Desenvolvimento de processo microfluídico para a complexação eletrostática 
entre lipossomas catiônicos e DNA: desenvolvimento de processos que 
permitam a complexação eletrostática entre LC e DNA em dispositivos 
microfluídicos de focalização hidrodinâmica única, similar ao estudado na 
segunda parte, com e sem blocos regulares nas paredes do microcanal, de 
modo a aumentar a área de contato entre os fluidos. 
3. Organização da Dissertação em Capítulos  
 A presente dissertação está organizada em capítulos, conforme descrito a 
seguir. Os resultados estão divididos na forma de artigos que serão submetidos a 
periódicos internacionais, selecionados de acordo com a afinidade do conteúdo 
abordado. Dessa forma, os itens introdução, metodologia, resultados e discussão 
e conclusões de cada etapa constam nos artigos em seus respectivos capítulos. 
 No Capítulo 2, Revisão Bibliográfica, são abordados os aspectos teóricos 
quanto ao Estado da Arte no âmbito em que essa pesquisa se insere. 
 No Capítulo 3, intitulado Correlation between Physicochemical and 
Structural Properties with In Vitro Transfection of pDNA/Cationic Liposomes 
Complexes, a caracterização físico-química aliada à estrutural pôde ser 
correlacionada com ensaios biológicos. Uma vez que a caracterização físico-
química dos complexos não foi suficiente para elucidar os diferentes níveis de 
transfecção obtidos para diferentes razões molares de cargas, foram conduzidas 
investigações de espalhamento de raios-x a baixo ângulo (SAXS - Small angle X-
ray scattering) a fim de avaliar as modificações estruturais, já evidenciadas por 
estudos de DLS por volume. As análises de SAXS mostraram que a população de 
vesículas com dupla bicamada cresce gradativamente com o aumento da razão 
molar de cargas, assim como observado na transfecção in vitro em células HeLa. 
Próxima à região de isoneutralidade de cargas, a queda nos níveis de transfecção 
foi explicada pelo aparecimento de outra população de partículas, com uma média 
de 5 bicamadas lipídicas, o que, provavelmente, interferiu na liberação do DNA às 
células. 
Capítulo 1 
33 
 
 Já no Capítulo 4, Continuous Flow Production of Cationic Liposomes at 
High Lipid Content in Microfluidic Devices for Gene and Vaccine Therapy, foi 
estudada a produção de lipossomas catiônicos em sistema contínuo em altas 
concentrações com o emprego de dois dispositivos microfluídicos. O primeiro com 
única focalização hidrodinâmica e o segundo com dupla, objetivando o aumento 
da área de contato entre os fluxos aquosos e orgânicos, e assim a área de 
difusão. Verificou-se que o dispositivo com dupla focalização hidrodinâmica é 
capaz de operar a vazões mais altas que o de focalização única. Os estudos de 
SAXS revelaram a predominância de lipossomas unilamelares em ambos os 
dispositivos. Estudos biológicos in vitro mostraram a potencialidade do processo 
para produzir essas estruturas lipossomais carreadoras de DNA. 
 O Capítulo 5, por sua vez, sob o título de Continuous Formation of 
DNA/Cationic Liposomes Complexes using Microfluidic Hydrodynamic Focusing 
Devices for Gene Delivery and Vaccine Therapy, investiga a utilização de sistemas 
microfluídicos para a formação de complexos DNA/lipossomas catiônicos em 
modo contínuo. Com o emprego de dois dispositivos e tendo o método de 
complexação convencional “bulk” como referência, os complexos obtidos através 
de os ambos dispositivos estudados – um de paredes dos microcanais com blocos 
padronizados e outro de parede simples – foram capazes de transfectar in vitro 
células humanas do tipo HeLa. O dispositivo simples atingiu níveis de transfecção 
similares ao alcançados pelos complexos obtidos pelo método “bulk”, enquanto o 
dispositivo com blocos nos microcanais apresentou menores níveis de 
transfecção. Isso provavelmente ocorreu devido à diferença de acomodação do 
DNA nas estruturas lipossomais, conforme mostrado nos ensaios de sonda de 
fluorescência. De modo geral, ambos os dispositivos foram capazes de produzir 
complexos de tamanho e polidispersidade controlados para aplicações em terapia 
e vacinação gênicas. 
 Por fim, a dissertação é fechada com dois outros capítulos: Conclusões 
Gerais e Sugestões para Trabalhos Futuros, em que são listadas as conclusões 
que os estudos desenvolvidos permitiram e em que também se sugere rumos para 
pesquisas futuras. 
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CAPÍTULO 2 – REVISÃO BIBLIOGRÁFICA 
____________________________________________________________________ 
 
1. Lipossomas 
 Lipossomas são estruturas aproximadamente esféricas de dimensões 
coloidais com cerne aquoso circundado por uma ou mais bicamadas lamelares 
lipídicas. São formados quando fosfolipídios se autoagregam espontaneamente 
em vesículas na presença de água, incorporando parte do meio em que se 
encontram. Pelo fato das lamelas mimetizarem membranas celulares, os 
lipossomas possuem diversas características biológicas, que incluem interações 
com biomembranas e com diversas células (LASIC, 1995). 
 Pela sua degradabilidade e não-toxicidade (que depende da sua 
composição), uma das principais vantagens da utilização de lipossomas é sua 
aplicação como transportadores de fármacos de qualquer natureza, como 
hidrofílicos, que se posicionam nos domínios aquosos internos, lipofílicos, que se 
localizam nas bicamadas, e anfifílicos, que se localizam entre ambos os domínios. 
As lamelas protegem os compostos carreados das agressões do meio biológico e 
promovem sua liberação sustentada (BATISTA, 2008). 
1.1. Veiculação de DNA em lipossomas catiônicos 
 Os lipossomas catiônicos apresentam-se promissores para a veiculação de 
DNA, pois permitem a sua proteção contra a degradação por fluidos corpóreos e 
complexação eletrostática. Além disso, a facilidade de interação com as células é 
uma característica intrínseca das estruturas lipídicas, devido à sua semelhança 
com a membrana celular (LABAS et al., 2010, DE ROSA & LA ROTONDA, 2009 e 
LASIC, 1993).  
O transporte efetivo de nucleotídeos para o interior das células foi 
conseguido com a utilização de lipídios catiônicos, como reportado por Felgner 
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(1987), em mecanismo denominado lipofecção. Desta forma, lipídios catiônicos 
foram usados para carrear nucleotídeos por meio de simples complexação 
eletrostática e para facilitar o seu transporte para o interior das células, por 
possuírem cargas opostas. Vários lipídios catiônicos sintéticos têm sido usados, 
dentre os quais os sais quaternários de amônio, tais como o brometo de 
dimetildioctadecil amônio (DDAB) e o 1,2-dioleoil -3-trimetilamônio-propano 
(DOTAP), são os mais conhecidos como carreadores de nucleotídeos (Labas et al. 
2010). 
 No processo de transporte para o interior das células, os nucleotídeos 
associados a lipossomas catiônicos são inicialmente internalizados 
preferencialmente através do mecanismo de endocitose. Em uma segunda etapa 
é necessário que os nucleotídeos sejam liberados da membrana endossomal para 
o citoplasma, possivelmente por ruptura da membrana que se desestabiliza devido 
a interações entre os lipídios catiônicos e suas moléculas aniônicas (Wattiaux et 
al., 1997). Dentro desse mecanismo, a presença de fosfatidoletanolaminas (PEs), 
também designadas como auxiliadores (do inglês, helpers), intensifica o processo 
de liberação por possuírem características fusogênicas, que facilitam a 
desestabilização da membrana endossomal (FELGNER et al., 1994). Porém, a 
fusão dos lipídios associados ao DNA com a membrana endossomal provocada 
pelas PEs não ocorre diretamente com a membrana citoplasmática, sendo 
necessária a etapa inicial da endocitose (Wrobel & Collins, 1995). Por essa razão 
as PEs são também designadas na literatura como co-lipídios em relação aos 
lipídios catiônicos.  
 Dentre as PEs, é mais conhecida a ação fusogênica do 1,2 dioleoil- sn-
glicero-3-fosfo etanolamina (DOPE). Sua importância nos estudos de 
potencialização da liberação dos nucleotídeos in vitro com lipídios catiônicos, 
deve-se à sua capacidade de passar para a fase hexagonal HII, facilitando a 
desestabilização da membrana endossomal e promovendo a liberação dos 
nucleotídeos no citoplasma através da troca de lipídios do endossoma com a 
membrana lipossomal.   
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 Em geral, a geometria molecular dos anfifílicos catiônicos e do DOPE, por si 
só não favorece a agregação em bicamadas lamelares nas condições fisiológicas. 
Os agregados formados são instáveis, havendo co-existência entre as fases 
lamelar e hexagonal tal como reportado por Rädler et al. (1997), com o DNA 
intercalado nas estruturas. A associação de lipídios catiônicos e DOPE com 
fosfolipídios estruturais tais como fosfatidilcolinas (PCs) é imprescindível para a 
formação de lipossomas, os quais são constituídos de bicamadas regulares ou 
lamelas, que se agregam intercalando domínios aquosos e gerando partículas 
coloidais aproximadamente esféricas.  
 Devido à correlação direta entre a fluidez da bicamada e a capacidade de 
transfecção (DUZGUNES et al.,1989), idealmente, a temperatura de transição de 
fazes das PCs deve ser baixa, o que é encontrado na fosfatidilcolina natural de 
ovo (EPC). Isso faz com que, a temperatura corpórea, os lipídios que constituem 
as estruturas lipossomais estejam no estado líquido-cristalino, o que lhes confere 
a fluidez necessária para facilitar a ação do DOPE e do lipídeo catiônico (DOTAP) 
no processo de internalização nas células. Além disso, a inclusão de EPC nas 
formulações demonstrou que a citotoxicidade in vitro é drasticamente reduzida 
(DE LA TORRE et al, 2009). 
 O desenvolvimento da nanoestrutura lipossomal incorporando o DNA-hsp65 
foi inicialmente realizado por de La Torre et al. (2006). A composição lipídica 
apresenta os três lipídios DOTAP/DOPE/EPC, com funcionalidades de 
incorporação do DNA e ligação eletrostática com a superfície das células, 
intensificação da liberação do DNA no citoplasma celular e estruturação em 
nanopartículas, utilizando a composição lipídica otimizada por Perrie et al. (2001). 
Os lipossomas foram preparados pelo método da desidratação-rehidratação com 
duas configurações referentes à localização do DNA nas nanoestruturas 
lipossomais: uniformemente distribuído no interior ou preferencialmente na 
superfície (TORRE et al., 2009 e ROSADA et al., 2008).  
 Os resultados mostraram que ambas as configurações foram capazes de 
incorporar o DNAhsp65 com eficiência elevada e capacidade de incorporar 50 µg 
de DNA em 100 µL de preparação lipídica (ROSADA et al., 2008, TORRE et al., 
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2009, TORRE, 2006). Além disso, as preparações foram reprodutíveis e estáveis 
durante a estocagem, apresentando níveis de citotoxicidade semelhantes ao do 
DNA nu (TORRE et al. 2009). A avaliação do efeito profilático mostrou a 
potencialidade da nanoestrutura lipossomal incorporando o DNA-hsp65 
preferencialmente na sua superfície (ROSADA et al., 2008). Além da sua eficácia 
profilática, esta vacina possui a vantagem adicional de ser mais efetiva pela via 
intranasal, que é uma via não invasiva, desejável para a administração de 
fármacos, com a redução da dose de 400 µg de DNA nu para 25 µg de DNA 
veiculado na nanoestrutura lipossomal (ROSADA et al., 2008). Desta forma, as 
nanoestruturas lipossomais complexando DNAhsp65 apresentaram-se 
promissoras para a produção de vacina para a tuberculose tanto do ponto de vista 
físico-químico quanto tecnológico (TORRE et al., 2006).  
 Uma vez que as pesquisas para a obtenção dos lipossomas “vazios” estão 
em andamento, a busca de novas estratégias para avaliação da complexação 
eletrostática entre os lipossomas catiônicos e o DNA vem sendo a próxima etapa 
de investigação, visando processos menos suscetíveis a variações de processo, 
além de garantir maior estabilidade durante a estocagem. 
 Uma alternativa para contornar estas dificuldades de processo é a 
realização da complexação eletrostática entre os lipossomas catiônicos e DNA em 
sistema microfluídico, permitindo um melhor controle dos processos difusionais e 
consequentemente, melhorando o controle do tamanho das partículas e sua 
estabilidade.  
1.2. Produção de lipossomas catiônicos 
 Apesar da grande quantidade de estudos na área e de demonstrar sucesso 
em suas aplicações, o número de produtos lipossomais aprovados em aplicação 
humana é pequeno. Dentre outras razões, isso se deve ao fato de não haver 
métodos de produção de lipossomas eficientes de baixo-custo (MOZAFARI, 2005). 
Em muitos dos métodos, a agregação coloidal não é completamente controlada 
levando a necessidade de utilização de operações unitárias subsequentes para a 
redução do tamanho. 
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 Há diversas técnicas de produção em escala laboratorial e algumas em 
larga escala (MOZAFARI, 2005). Dentre os métodos tradicionais de produção 
laboratorial de lipossomas, o proposto por Bangham é, provavelmente, um dos 
mais utilizados (LESOIN et al., 2011). O método consiste na dispersão dos lipídios 
em uma fase orgânica e sua posterior remoção, formando um filme seco de 
lipídios, que é então hidratado com uma solução aquosa. Outros métodos 
tradicionais, como o método de injeção de etanol, de evaporação da fase reversa 
e emulsão, também se baseiam na produção de uma solução lipídica com um 
solvente orgânico antes da dispersão em uma fase aquosa. Todos esses métodos 
necessitam de uma operação unitária posterior à produção dos lipossomas para 
atender tamanhos e polidispersidade de tamanhos requeridos. Os métodos mais 
comuns de redução/uniformização do tamanho dos lipossomas são sonicação, 
extrusão e homogeneização a alta pressão (MEURE et al., 2008). 
 Os métodos mais recentes desenvolvidos para a produção de lipossomas 
abordam técnicas que utilizam altas temperaturas, liofilização de soluções 
monofásicas, fluidos supercríticos e microcanais (MEURE et al., 2008). Os 
processos que utilizam gás denso e fluidos supercríticos utilizam apenas uma 
pequena quantidade de solvente orgânico, além de possibilitarem a esterilização 
in situ (LESOIN et al., 2011). Todos os novos métodos exploram técnicas que 
visam a intensificação do processo, para que sejam em uma única etapa, atendam 
às especificações de Boas Práticas de Fabricação, eliminem a utilização de 
solventes, diminuam a complexidade e o tempo de produção (MEURE et al., 
2008). Apesar de alguns serem passíveis de escalonamento, nenhum desses 
métodos opera em regime contínuo, exceto a produção de lipossomas em 
microcanais a baixa pressão. 
 Em geral, os métodos para produção de nanopartículas podem ser divididos 
em duas abordagens: “top-down” e “bottom up”. A abordagem top-down é a forma 
mais usada de obtenção de nanopartículas. Primeiramente, as partículas são 
obtidas em grande tamanho, e com a aplicação de forças de alta energia, o 
tamanho é reduzido para escalas nanométricas. Na abordagem bottom up, as 
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nanopartículas são formadas diretamente no tamanho desejado, pela auto-
organização das moléculas (TREVISAN, 2010). 
 A busca por processos que forneçam lipossomas com tamanhos menores e 
com menor polidispersidade vem da necessidade de melhorar a aparência 
macroscópica da preparação e sua possível esterilização, e melhorar a 
estabilidade física em termos de sedimentação e flotação. Adicionalmente, quanto 
menor o tamanho dos lipossomas, o processo de remoção da corrente sanguínea 
é prolongado, elevando o tempo de circulação na corrente sanguínea, viabilizando 
aplicações intravenosas (TORCHILIN & WEISSIG, 2007). 
 Além disso, para aplicações dos lipossomas catiônicos em transfecções in 
vitro, o tamanho e a polidispersidade da dispersão é fundamental para garantir a 
condição ideal para a entrada dos complexos lipossomas-DNA nas células. Uma 
alternativa promissora para o controle do tamanho é a área de microfluídica. 
2. Microfluídica 
 Microfluídica é um campo multidisciplinar que estuda fluidos em volumes 
milhares de vezes menores que uma gota (10-9 a 10-18 litros). Além de pequenas 
dimensões e quantidade de fluidos, a microfluídica explora características 
hidrodinâmicas para organizar no espaço e no tempo fluxos de fluidos como 
reagentes químicos, células, lipídios, ácidos nucléicos (DRAGHICIU et al., 2010; 
BAEK et al., 2011; YAMASHITA et al., 2011; REINER et al., 2010; KURITA et al., 
2010). Esta ciência está entre as áreas que mais têm crescido na pesquisa 
científica e no desenvolvimento tecnológico (LI, 2008).  
 Os dispositivos micrométricos projetados para realizar tarefas específicas 
têm demonstrado superioridade sobre seus análogos em macroescala (LUTZ, 
2002). As especificidades destes sistemas conferem diversas vantagens em 
relação aos sistemas fluídicos convencionais: tamanho mínimo de dispositivos; 
menor consumo de amostra e reagente; controle preciso de fenômenos de 
transferência térmico e mássico; escoamento estritamente laminar; reações muito 
mais rápidas; baixo consumo e dissipação de energia; baixo custo relativo de 
produção por dispositivo.  
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 A estratégia de aumento de produção (“scale-up”) se dá de forma diferente 
dos processos fluídicos, uma vez que estes últimos requerem aumento do 
tamanho dos equipamentos e das vazões de processo. O aumento de produção 
dos processos microfluídicos ocorre em termos de amplificação de processos, isto 
é, os dispositivos não são alterados em suas dimensões, mas sim, montados em 
paralelo de forma a se elevar a produção por réplica. Assim, os dispositivos são 
portáteis, possuem elevada superfície de contato entre os fluidos em relação ao 
volume e possibilitam a fácil amplificação da produção, utilizando sistemas em 
paralelo e, em algumas vezes, até mesmo dispositivos descartáveis (JAHN et al., 
2010; LUTZ et al., 2002; TERRAY et al., 2002; SEKHON et al., 2010; TIAN et al., 
2009).  
 Uma nova perspectiva que tem recebido muita atenção na engenharia 
química moderna, que concerne a inovações que reduzem o tamanho da planta e 
consumo de energia em várias ordens de grandeza para um determinado objetivo, 
é a Intensificação de Processo. Esta perspectiva consiste no desenvolvimento de 
novas tecnologias que tragam melhorias na produção e processamento, reduzindo 
substancialmente a produção de resíduos e a razão tamanho de equipamento/ 
capacidade de produção, que sejam mais eficientes energeticamente, resultando 
em tecnologias sustentáveis mais baratas (STANKIEWICZ et al., 2000 e 2009; 
SPOORTHI et al., 2010). Neste contexto, a microfluídica se apresenta como uma 
forma de alcançar a intensificação de processo, integrando em uma única etapa 
determinados processos e etapas subsequentes de produção, além de minimizar 
efeitos de transferência de calor e massa, pela própria dimensão dos dispositivos. 
 As técnicas utilizadas para a fabricação dos dispositivos dependem do 
material a ser empregado, que deve se adequar a aplicação preterida de acordo 
com as características físicas e químicas desse material. A utilização de vidro e 
polímeros para a produção de microdispositivos é amplamente utilizada, pois tais 
materiais unem boas propriedades químicas e físicas a baixo custo, além de 
permitirem a fácil estruturação do sistema que constituem o dispositivo, isto é, 
canais, orifícios, colunas, bombas, válvulas etc (LI et al., 2010; BECKER et al., 
2001). Atualmente, diversas tecnologias para a fabricação de dispositivos 
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microfluídicos são empregadas: impressão e estampagem a quente, moldagem 
por injeção, litografia macia, fotoablação a laser, litografia de raio-x, dentre outros 
(BECKER, 2001).  
 As aplicações da microfluídica na biotecnologia são uma interessante área 
que começou a revolucionar a forma como pesquisadores estudam e manipulam 
macromoléculas (BELTHIER, 2006). Os avanços na microfabricação permitem 
que tais sistemas operem com diversos biomateriais com investigações nas 
diversas áreas desde o desenvolvimento de biorreatores, processos de separação 
e também para a obtenção de nanopartículas para diversas aplicações 
(BETTINGER, 2010).  
 A obtenção de nanopartículas em microcanais é uma das aplicações que 
tem se mostrado uma alternativa promissora para superar obstáculos existentes 
nos métodos convencionais de produção, como o controle da polidispersidade, do 
tamanho de partícula e do potencial zeta. Devido à flexibilidade desses 
dispositivos para operar com uma variedade de diferentes materiais, vários tipos 
de nanopartículas obtidas por síntese, formação ou auto-agregação em 
microcanais são reportadas na literatura, como niosomas, emulsões, nanocristais, 
partículas de PLGA e lipossomas (LO et al., 2010; PERRO et al., 2010; ZHAO et 
al., 2010; SHAN et al., 2003). 
3. Produção de Lipossomas em Microcanais 
 O escoamento em multicanais que utilizam os princípios da microfluídica 
vêm sendo uma das alternativas mais estudadas para a produção de lipossomas 
pré-formados produzidos sem a necessidade de etapas subsequentes ao 
processo para redução do tamanho e da polidispersidade, além de operarem em 
regime contínuo (JAHN et al., 2003 e 2007). Esta é uma abordagem bottom up, 
pois visa à produção dos lipossomas já no tamanho e polidispersidade 
apropriados para a aplicação biológica. 
 A formação dos lipossomas nos microcanais que utilizam o princípio da 
focalização hidrodinâmica ocorre através do contato de duas fases de fluidos 
solúveis entre si, uma aquosa e outra orgânica. A fase orgânica é aquela na qual 
Capítulo 2 
43 
 
os lipídeos estão dispersos em um solvente, como etanol ou isopropanol. Dessa 
forma, ocorre a difusão entre essas fases.  Conforme ocorre essa difusão na 
interface entre as fases, os lipídeos se tornam cada vez menos solúveis no meio 
aquoso, e começam a se agregar, formando discos de bicamadas lipídicas 
planares. À medida que essas bicamadas lipídicas planares crescem, elas 
começam a se ligar a fim de diminuir a área superficial das cadeias hidrofóbicas 
dos lipídeos expostas pelas extremidades ao meio aquoso. Dessa forma, os 
discos se fecham em vesículas esféricas com uma bicamada separando um meio 
aquoso no cerne do meio externo (ZOOK et al., 2010).   
 
Figura 1. (A) Ilustração da construção do filme lipídico. Água, óleo com lipídios e água 
são seqüencialmente injetados no canal principal do dispositivo microfluídico, que contém 
microcâmaras em sua parede. (B) Bombas pneumáticas são acionadas formando 
vesículas lipídicas, que saem pelo canal principal (fonte: KURAKAZU et al., 2010). 
 Dentre os trabalhos que focam a formação de lipossomas em dispositivos 
microfluídicos, Kurakazu et al. (2010) estudaram a formação de lipossomas 
gigantes utilizando um sistema microfluídico de junção T com válvulas 
pneumáticas.  A operação do aparato se dava com a passagem sequencial de 
água, solução de óleo contendo os lipídios e água novamente, por um canal com 
microcâmaras distribuídas ao longo de sua parede, como mostra a Figura 1A. A 
água da primeira passagem preenchia as microcâmaras, que posteriormente eram 
seladas com a membrana de bicamada lipídica formada na interface dos líquidos. 
Válvulas pneumáticas empurravam a água de dentro das câmaras para fora, 
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fazendo com que os lipossomas fossem formados encapsulando a água da 
primeira passagem (Figura 1B). Com esse sistema, é factível a produção de 
lipossomas monodispersos e unilamelares de forma contínua. Um dispositivo com 
operação similar, foi elaborado por Ota et al. (2009), que formaram lipossomas de 
tamanho de diâmetro entre 18 e 31 m. Os lipossomas eram formados 
encapsulando calceína, que estava em solução na primeira fase aquosa a passar 
pelo canal. 
 Utilizando injeção cruzada de lipídios dispersos em etanol, Wagner et al. 
(2002) produziram uma população homogênea de lipossomas. Este processo, 
denominado também de focalização hidrodinâmica, representa um melhoramento 
em relação ao método tradicional de injeção de etanol, em que a mistura lipídio-
etanol é lentamente injetada em um tanque agitado contendo solução aquosa 
tamponada. O processo de injeção cruzada mostrou maior facilidade de controle 
do tamanho das partículas, sendo mais reprodutível que o processo convencional. 
As partículas geradas apresentaram diâmetros na faixa de 200 a 500nm. 
 
Figura 2. (A) Diagrama esquemático do processo de formação de lipossomas em canal 
microfluídico. A relação de cores representa as razões de concentração de álcool 
isopropílico e tampão aquoso. (B) Mapa 3-D de intensidade de fluorescência durante 
formação de lipossomas (adaptado de JAHN et al., 2004). 
 Jahn et al. (2004 e 2007) descreveram a formação de lipossomas em uma 
rede de microcanais, conforme ilustrado na Figura 2. Os lipossomas foram 
formados por um processo controlado pela difusividade, quando uma corrente de 
lipídios dispersos em solvente orgânico é hidrodinâmicamente comprimido por 
duas correntes aquosas tamponadas. Os lipossomas formados apresentaram 
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tamanhos de 50 a 150nm, com distribuição de tamanhos menor e maior 
reprodutibilidade quando comparados aos produzidos pelo processo convencional 
de injeção de etanol (“bulk”). Este processo é sensível à geometria do canal e à 
razão entre as vazões volumétricas de álcool e água, sendo essa última razão, a 
variável controladora do processo. A formação dos lipossomas foi também mais 
fortemente dependente da corrente de solvente orgânico e da sua difusividade na 
corrente aquosa, do que das forças de cisalhamento na interface solvente-solução 
tampão. 
 Utilizando um dispositivo microfluídico imerso em um banho de ultra-som, 
Huang et al. (2010) obtiveram lipossomas monodispersos com tamanho médio de 
partícula entre 50 e 150 nm. Com a sonicação, o tamanho de partícula foi reduzido 
significativamente quando comparado com os lipossomas produzidos sem 
sonicação. Segudno os autores, isso se deve provavelmente ao fato de que, com 
o processo de sonicação, pode haver cavitação no sistema, melhorando a 
dispersão das moléculas de lipídio e consequentemente, reduzindo o tamanho dos 
lipossomas. Os autores também observaram que o tamanho dos lipossomas 
obtidos nos microcanais diminui com o aumento da razão entre as taxas de fluxo 
aquosa e alcoólica/lipídica (do inglês, Flow Rate Ratio – FRR). O aumento de FRR 
promove a formação de lipossomas em concentração lipídica menor. 
 Trevisan et al. (2011), empregando a mesma composição lipídica do 
presente trabalho, produziu lipossomas catiônicos em altas concentrações em 
dispositivos microfluídicos de vidro. A concentração lipídica da dispersão etanólica 
utilizada foi muito acima àquelas reportadas na literatura, variando entre 100 e 400 
mM. Entretanto, provavelmente devido às altas concentrações empregadas não se 
adequarem a produção de LC em sistemas microfluídicos, os lipossomas obtidos 
não apresentaram bom controle de tamanho e polidispersidade. 
 A produção de niossomas também é factível em microcanais (LO et al., 
2010). Niossomas são e são formadas pela auto-agregação de tensoativos não-
iônicos. Os niosomas são comumente usados como transportadores de agentes 
de tratamento para aplicações farmacêuticas e cosméticas. Comparada com o 
método tradicional, a produção em microcanais se mostrou mais eficiente tanto no 
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controle do tamanho das partículas, quanto na sua polidispersidade. Pelo fato dos 
sistemas microfluídicos apresentarem uma mistura rápida e controlada dos dois 
fluidos miscíveis (álcool e água) foi possível a obtenção de niossomas com 
distribuição de tamanho 40% menor em comparação com o método tradicional, 
sugerindo a factibilidade do desenvolvimento e otimização de sistemas coloidais 
em dispositivos microfluidicos para a aplicação em nanomedicina. 
4. Sistemas Microfluídicos para a complexação eletrostática entre 
lipossomas catiônicos e DNA 
 A formação de vetores não virais depende do empacotamento apropriado 
do DNA em sua estrutura. As interações eletrostáticas entre os lipídeos catiônicos 
e o DNA produzem estruturas auto-agregadas em partículas de tamanho e 
morfologia diversas (MANNISTO et al., 2002 e OBERLE et al., 2000), que 
dependem de fatores tais como a razão molar de cargas positivas/negativas, força 
iônica do tampão, ordem de mistura, condições de reações, tipo de lipídeo 
(TORRE, 2006, MOUNT et al., 2003 e ZELPHATI et al., 1998). 
 A variação dos resultados de transfecção reflete muitas vezes a dificuldade 
de controle do processo de auto-agregação e tem como consequência a produção 
de partículas de elevado grau de polidispersidade, levando a formação grandes 
frações das populações fora da faixa de tamanho correta para a transfecção da 
célula alvo do estudo (HSIEH et al., 2009). Vários autores reportaram que o 
tamanho dos complexos lipossoma-DNA é um parâmetro que influencia 
diretamente a transfecção gênica (MA et al., 2007, REJMAN et al., 2004, 
WIEWRODT et al. 2002, ROSS & HUI, 1999, OGRIS et al., 1998). Neste contexto, 
o desenvolvimento de processos que promovam o controle da complexação 
eletrostática entre os lipossomas catiônicos e o DNA, que permitam a formação de 
partículas uniformes e de forma reprodutiva, resultará consequentemente em 
transfecções uniformes. Estes resultados são fundamentais para o 
desenvolvimento de produtos farmacêuticos que veiculam tanto DNA como 
também RNA.  
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 Uma abordagem recente no estudo do controle do tamanho destas 
partículas é a utilização de processos microfluídicos. Estes sistemas permitem e 
realização da complexação eletrostática em fluxo contínuo, com o controle do 
cisalhamento e das condições difusionais, permitindo a orientação de 
macromoléculas. O método da focalização hidrodinâmica também têm sido 
utilizado em estudos de complexação eletrostática entre DNA e lipossomas 
catiônicos (OTTEN et al., 2005; JELLEMA et al., 2010), dendrímeros (DOOTZ et 
al, 2006) e polietilenoimina (KOH et al., 2009), bem como lipossomas catiônicos e 
RNA, visando a caracterização físico-química destas partículas. 
Adicionalmente, a focalização hidrodinâmica leva a formação de estruturas mais 
organizadas. O regime de escoamento laminar também permite que a 
compactação do DNA seja controlada pelo processo difusional, contribuindo para 
a maior organização estrutural (DOOTZ et al., 2006). Este processo permite que 
agregados formados em microcanais sejam mais compactos, porém dependentes 
principalmente das velocidades superficiais dos fluidos (DOOTZ et al., 2006). 
 
Figura 3: Representação esquemática do sistema microfluídico de focalização 
hidrodinâmica para a formação do sistema auto-agregado lipossoma catiônico-DNA 
(Fonte: KOH et al. 2005). 
 Otten et al. (2005) elaboraram um aparato microfluídico, baseado na 
focalização hidrodinâmica, conforme apresentado na Figura 3, objetivando a 
investigação do comportamento dinâmico na formação de complexos lipossoma 
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catinônico-DNA. O DNA é inserido na posição central da focalização 
hidrodinâmica e os lipossomas catiônicos pré-formados têm seu fluxo dividido em 
duas entradas laterais, comprimindo hidrodinamicamente a corrente de DNA. Este 
esquema é similar ao realizado experimentalmente em nosso grupo de pesquisa 
para a obtenção dos lipossomas “vazios” (ou pré-formados) (TREVISAN et al., 
2011). 
 A largura da corrente líquida focalizada pode ser ajustada de acordo com as 
taxas de escoamento entres as fases. De acordo com o regime laminar, a mistura 
é controlada somente pelo processo difusivo. Reduzindo a largura da corrente 
líquida focalizada, ocorre a diminuição do comprimento no qual o processo 
difusivo ocorre e consequentemente a mistura ocorre mais rapidamente (KNIGHT 
et al., 1998). Em seus estudos, Otten et al. (2005), utilizaram uma solução de DNA 
(calf thymus DNA) em 5 mg.mL-1, com velocidade superficial de 100 mm.s-1. A 
dispersão aquosa dos lipossomas catiônicos (diâmetro médio hidrodinâmico 
inferior a 200 nm), formados por DOTAP e DOPC (dioleoyl-phosphatidylcholine) 
(1:1) (concentração lipídica de 25 mg.mL-1), com velocidade superficial de 
vLipossomas = 13vDNA e vLipossomas = 130vDNA. Neste estudo os autores verificaram que 
o processo de auto-agregação ocorre em duas etapas: a primeira, na qual ocorre 
a formação do complexo multilamelar e uma segunda, na qual ocorre um rearranjo 
do DNA dentro das lamelas. 
 Outro aparato microfluídico também é reportado em uma patente 
internacional (LEE et al. 2009), que descreve a obtenção de nanopartículas 
formadas por lipídeos e oligonucleotídeos para a liberação de DNA ou RNA para 
células de câncer. Neste caso os lipídeos são dispersos em uma fase orgânica 
(miscível em água) e os oligonucleotídeos (DNA ou RNA) são solubilizados em 
água. A mistura destas duas correntes em sistema microfluídico permite a 
formação do sistema nanoparticulado de entrega de genes. De acordo com os 
autores, o sistema microfluídico permite a formação de nanopartículas de tamanho 
bem definido, bem como estrutura e função farmacológica (Patente internacional 
WO2009120247-A2, 2009). 
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 Jellema et al. (2010) utilizaram um sistema de fluxo contínuo para a 
complexação eletrostática entre lipossomas catiônicos formados com os lipídios 
DOPE/DOTAP e DNA. Um micromisturador com 12 estágios foi empregado para 
preparar os complexos lipossomas-DNA na razão de cargas apropriada. 
Lipoplexos com uma estreita distribuição de tamanhos foram eficientemente 
obtidos utilizando essa técnica. 
 Um dispositivo multi-entradas de focalização hidrodinâmica foi estudado 
para a formação complexos contendo mRNA por Koh et al. (2010).  Os melhores 
resultados foram obtidos utilizando uma configuração de 3 canais: no canal, a 
solução de mRNA era injetada, enquanto nas entradas laterais eram injetadas as 
correntes lipídicas. O diâmetro hidrodinâmico das partículas variou entre 100 e 
300 nm. Comparado com o método bulk, as nanopartículas obtidas pelo sistema 
microfluídico apresentaram menores tamanho e polidispersidade, além de 
propiciar a produção de estruturas mais uniformes. Esses complexos também se 
mostraram eficientes em aplicações biológicas in vitro.  
 Neste contexto, o desenvolvimento de processos que promovam o controle 
da complexação eletrostática entre os lipossomas catiônicos e o DNA, que 
permitam a formação de partículas uniformes e de forma reprodutiva, resultará 
consequentemente em transfecções mais eficientes. Estes resultados são 
fundamentais para o desenvolvimento de produtos farmacêuticos que veiculam 
tanto DNA como também RNA para aplicação em vacinação e terapia gênica.  
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Abstract 
 In this study, we characterized the conventional physicochemical properties of the 
complexes formed by pDNA (pDNA) and cationic liposomes (CL) composed of egg 
phosphatidylcholine (EPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) 
and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) (50/25/25% molar ratio). We 
found that these properties are nearly unaffected at the studied ranges when the molar 
charge ratio (R+/-) between the positive charge from the CL and negative charge from 
pDNA is not close to the isoneutrality region (R+/-=1). However, the results from in vitro 
transfection of HeLa cells showed important differences when R+/- is varied, indicating 
that the relationships between the physicochemical and biological characteristics were 
not completely elucidated. To obtain information regarding possible liposome structural 
modifications, small angle x-ray scattering (SAXS) experiments were performed as a 
function of R+/- to obtain correlations between structural, physicochemical and 
transfection properties. The SAXS results revealed that pDNA/CL complexes can be 
described as being composed of single bilayers, double bilayers and multiple bilayers, 
depending on the R+/- value. Interestingly, for R+/-=9, 6 and 3, the system is composed of 
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single and double bilayers, and the fraction of the latter increases with the amount of 
DNA (or a decreasing R+/-) in the system. This information is used to explain the 
transfection differences observed at an R+/-=9 compared to R+/-=3 and 6. Close to the 
isoneutrality region (R+/-=1.8), there was an excess of pDNA, which induced the 
formation of a fraction of aggregates with multiple bilayers. These aggregates likely 
provide additional resistance against the release of pDNA during the transfection 
phenomenon, reflected as a decrease in the transfection level. In conclusion, the 
obtained results permitted proper correlation of the physicochemical and structural 
properties of pDNA/CL complexes with the in vitro transfection of HeLa cells by these 
complexes, contributing to a better understanding of the gene delivery process. 
1. Introduction  
Gene delivery is a promising strategy for the treatment of different diseases, 
including gene-related disorders, infectious diseases and cancer [1-3]. However, the 
success of gene delivery depends on the efficiency of the transfection process, which is 
based on the introduction of engineered DNA encoding a functional/therapeutic protein 
into the cell nucleus to modulate cellular functions and responses [4, 5]. However, 
because efficient delivery requires protection of DNA against nucleases and interstitial 
fluids, a wide variety of carriers are employed to efficiently deliver nucleic acids to target 
cells with high transfection efficiencies [6]. Viral gene delivery is an alternative method 
that promotes transfection at a high level. However, oncogenic effects are a major 
drawback of viral gene deliver [7, 8]. 
Another important strategy is the use of nonviral systems, such as cationic 
polymers or lipids. These systems present lower transfection efficiencies compared to 
viral carriers but are safer [9]. In the field of nonviral gene delivery systems, different 
factors may influence transfection efficiency, such as the nature and cytotoxicity of the 
carrier, DNA entrapment in carrier structures, the zeta potential of the structures, the 
culture conditions in the case of in vitro transfections, and the cell line employed [10, 
11]. In addition to the factors that influence transfection efficiency, the particle size of the 
complexes is also relevant, as it has an important impact on the efficiency of cellular 
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uptake and the subsequent intracellular processing [12]. Among many nonviral carriers, 
the cationic liposomes (CLs) have long been investigated. 
Liposomes are self-assembled phospholipid aggregates that mimic the cell 
membrane. The use of cationic lipids allows the formation of cationic liposomes that can 
form complexes with pDNA through electrostatic interactions. Since the first utilization of 
pDNA/CL complexes as nonviral vectors by Felgner and co-workers [13], many cationic 
liposomal formulations have been extensively applied in gene delivery studies, 
employing different lipid compositions [14-17]. The transfection process using CLs is 
simple and is tolerated by cells. Basically, the pDNA/CL complexes associate with the 
cell membrane, which allows DNA internalization and release into the cell cytoplasm 
[11]. 
Liposomes have been successfully applied in in vitro and in vivo gene delivery 
studies. A liposomal formulation was optimized for tumor-targeting delivery of an 
anticancer small-molecule and significantly improved the anticancer effect in human 
melanoma and prostate cancer cells [18]. In vivo experiments also showed the feasibility 
of using CL for delivering genes, resulting in the induction of effective immune 
responses [19, 20].  
Despite the promising results regarding gene delivery using CLs, the 
physicochemical and structural characteristics of CLs and their relationship with 
biological results remain unclear. Several research groups have struggled in attempts to 
correlate the physicochemical properties observed in in vitro transfection experiments 
and structural properties, but the results obtained thus far do not completely elucidate 
the differences in transfection efficiency found in vitro and in vivo [21]. It has been 
reported that the structures of pDNA/CL complexes do not show any influence on 
transfection efficiency, suggesting that they are not correlated [22]. In contrast, Savva 
and co-workers [23] correlated the efficiency of the transfection of pDNA/CL complexes 
with their structural properties by means of membrane elasticity analyses.  
A similar conclusion was obtained from fluorescence anisotropy results, which 
indicated that the fluidity of liposome and lipoplex membranes is also related to better 
transfection results [24]. This clear disagreement between the reported results is difficult 
to address, principally because the studied systems involved different lipid compositions, 
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DNA sequences and cell types, impairing the possibility of establishing a pattern or any 
general conclusion. One possible way to obtain important structural information about 
pDNA/CL complexation is through the use of the small angle x-ray scattering (SAXS) 
technique, which is a powerful tool for structural characterization of amphiphilic systems 
providing information on the electronic contrast of bilayers and several other structural 
parameters, such as membrane periodicity, size and fluidity. Despite all of the 
information that can be obtained from scattering experiments, only a few publications 
have reported the use of this technique to its full potential, particularly for drug delivery 
systems. In this work, we propose a modeling procedure that allowed DNA complexation 
to be described. As shown below, analysis of scattering data permitted the description of 
systems with different liposome membrane formulations, relating the cationic lipid 
content to the transfection results [15]. 
In previous work, we demonstrated the in vivo efficacy of CL composed of egg 
phosphatidylcholine (EPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) 
and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) (50/25/25% molar) in 
dehydrated-hydrated vesicles (DRVs) for vaccination against tuberculosis [25, 26] and 
hepatitis B [27]. Using this lipid composition, in in vivo analyses of tuberculosis 
vaccination using a unique dose administered via the intranasal route, a 16-fold 
reduction was achieved in the amount of plasmid DNA employed [25, 26]. This 
formulation was also viable for producing multifunctional nanoparticles with different 
domains when associated with a synthetic peptide. This pseudo-ternary complex 
(peptide/pDNA/CL) presented therapeutic effects against tuberculosis [2]. In this work, 
the same lipid composition of DRVs was employed for tuberculosis vaccination, but with 
extruded cationic liposomes and the plasmid DNA vector pVAX-Luc encoding a 
luciferase reporter gene being used to produce pDNA/CL complexes. The electrostatic 
effects of complexation between CLs and pDNA on physicochemical and structural 
properties were evaluated in SAXS experiments, permitting correlation with the results 
of in vitro transfection of HeLa cells.  
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2. Materials and Methods 
2.1. Materials 
The plasmid pVAX1 encoding luciferase was used as a modified version of 
pVAX1-GFP, following the description of Toledo et al. [28]. Basically, the sequence 
encoding Luciferase protein was removed from the pGL3-Luc Control vector using the 
XbaI and EcoRI restriction endonucleases. A similar procedure was carried out to insert 
LUC in the vector pVAX1, replacing the GFP gene. Therefore, the vector used here has 
the same pVAX backbone, but luciferase is used as the reporter gene. This vector was 
designated pVAX-Luc. The performance of pVAX-Luc was assessed via transfection 
assays based on correct luciferase expression. 
Egg phosphatidylcholine (EPC) (96% of purity), 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) (99.8% of purity) and 1,2-dioleoyl-3-trimethylammonium-
propane (DOTAP) (98% of purity) were purchased from Lipoid and used without further 
purification. Other materials were of analytical grade. 
2.2. Plasmid DNA purification 
PVAX-Luc was amplified in Escherichia coli bacteria and purified using the 
PureLink™ HiPure Plasmid DNA Purification Kit-Maxiprep K2100-07 (Invitrogen, 
Maryland, USA). The plasmid concentration and purity were determined 
spectrophotometrically at 260 nm (A260) using a Nanodrop UV spectrophotometer ND-
1000 (PeqLab, Erlangen, Germany). An A260 nm/A280 nm ratio higher than 1.8 was 
used as the criterion for purity. 
2.3. Preparation of pVAX-Luc/cationic liposome complexes (pDNA/CL) 
pDNA/CL complexes were obtained as described previously by adding the 
appropriate amount of pDNA to CL under intense vortexing at 4oC for at least 40 s [26]. 
pDNA/CL complexes were prepared at different cationic lipid:DNA molar charge rates 
(R+/−)  [29]. 
Cationic liposomes were prepared via the thin film method [30]. Briefly, a mixture 
of EPC, DOPE and DOTAP (50/25/25% molar) [26] was solubilized in chloroform, and 
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the solvent was subsequently removed in a rotary evaporator under a vacuum of 650 
mmHg for 1 h. The dried lipid film was hydrated with PBS buffer to a final lipid 
concentration of 16 mM. The hydrated liposomes were extruded through double 
polycarbonate membranes (100 nm nominal diameter) 15 times under nitrogen (12 
kgf/cm²).   
2.4. Physicochemical Characterization 
2.4.1. Average Hydrodynamic Diameter and Polydispersity 
The average hydrodynamic diameter and size distribution were measured via the 
dynamic light scattering (DLS) technique using a Malvern Zetasizer Nano ZS with a 
backscattering configuration with detection at a scattering angle of 173° using a He/Ne 
laser emitting at 633 nm and a 4.0 mW power source. Each measurement was repeated 
in triplicate, and the obtained values were averaged to obtain the mean particle size 
weighted by number and volume. 
The polydispersity index was calculated from cumulant analysis of the measured 
DLS intensity autocorrelation function. The polydispersity index varied from 0 to 1 
(higher values indicate a less homogeneous nanoparticle size distribution). The mean 
diameter and polydispersity index of particle sizes were estimated via CONTIN algorithm 
analysis through inverse Laplace Transformation of the autocorrelation function.  
2.4.2. Measurement of Zeta Potential  
The zeta potential (ζ) was measured by applying an electric field across the 
samples, and the value of the zeta potential was obtained by measuring the velocity of 
the electrophoretic mobility of the particles using the laser Doppler anemometry 
technique. The measurements were performed three times for each sample at 25°C 
using a Malvern Zetasizer 3000 in water. 
2.4.3. Gel retardation assay for determining the molar charge ratio for complete 
DNA complexation with CL 
Agarose gel electrophoresis was used to determine the molar charge ratio for 
complete pDNA complexation with CL. pDNA/CL complexes at different cationic:anionic 
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molar charge ratios (R+/-) (containing 1 g of pDNA) were run in 0.8% agarose gels in 
40 mM TRIS-acetate buffer solution and 1 mM EDTA (TAE 1X) at 60 V for 3 h, followed 
by staining for 30 min in a 0.5 g/mL ethidium bromide solution. The EtBr-stained DNA 
bands were then visualized and photographed using an ultraviolet image acquisition 
system. 
2.4.4. Morphology  
We employed transmission electron microscopy and the negative staining method 
to study the morphology of CL and pDNA/CL complexes. For this analysis, a LEO 906E 
electron microscopic (Zeiss, Germany) was used at 80 kV, together with a MEGA VIEW 
III /Olympus camera and ITEM E 23082007/ Olympus Soft Imaging Solutions GmbH 
software. Briefly, 5 μL of CL or pDNA/CL complexes was added to a carbon-coated grid 
for 5 min, and the excess liquid was then blotted, leaving a thin aqueous film on the grid. 
Negative staining was performed with a 2% solution of ammonium molybdate for 10 s, 
followed by blotting the samples dry.  
2.5. In Vitro Cytotoxicity 
We evaluated the in vitro cytotoxicity of the pDNA:CL complexes in HeLa cells 
employing the cell proliferation reagent WST-1 from Roche Molecular Biochemicals 
(Mannheim, Germany). The commercial transfection reagent Lipofectamine® and 
“naked” pVAX-LUC were used as reference. The cells were seeded into 96-well 
microplates in 100 μL of culture medium (7,000 cells per well), and after incubation for 
48 h (37 °C, 5% CO2), the complexes were added. At the end of the treatment, 10 μL of 
the cell proliferation reagent WST-1 was added to each well. The cells were incubated 
under the prior conditions for 2 h. Absorption was measured with a scanning multiwell 
spectrophotometer following gentle agitation (1 min) (ELISA-Reader MRX, Dynex 
Technologies, Chantilly, USA) at detection wavelength of 440 nm, and a reference 
wavelength of 650 nm was used to subtract nonspecific signals.  
Viable cells converted WST-1 to a yellow-orange water-soluble formazan dye that 
was detectable at 420 – 480 nm. The absorbance was directly correlated with the cell 
numbers present. The experiments were performed in hexaplicate. The percentage of 
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viable cells in comparison to the control (untreated cells) was calculated using the 
following equation: % viable cells = [(OD440treated – OD650treated) /(OD440control – 
OD650control)]×100.    
2.6. Culture and transfection of mammalian cells 
The complexes were tested in vitro using the plasmid pVAX-Luc in human 
epithelial carcinoma cells (HeLa cells) according to Toledo et al. [28]. The cells were first 
cultured in 75 cm2 flasks using the F-12 (Ham) nutrient mixture (Gibco, UK) containing 
10% (v/v) fetal bovine serum (FBS) (Gibco, UK) and supplemented with non-essential 
amino acids (Gibco, UK), gentamicin (Gibco, UK), sodium pyruvate (Gibco, UK), and an 
antibiotic–antimycotic solution (Gibco, UK). The cultures were incubated in 5% CO2 
humidified environment at 37°C. The cells were trypsinized after reaching confluence 
and then seeded into 24-well culture plates (5104 cells per well). Next, the cells were 
incubated for 48 h and transfected using the pDNA/CL complexes at different R+/- with 
statistically equals amounts of pVAX-LUC per well. Finally, the medium was replaced 6 
h after transfection to remove plasmids that were not internalized by the cells. The 
commercial transfection reagent Lipofectamine® was used as a positive control 
following the manufacturer’s protocol, and naked plasmid DNA was employed as a 
negative control. 
Subsequently, the medium was removed; the cells were washed using PBS and 
lysed; and luciferase activity was determined according to the Promega Luciferase 
Assay protocol. The Relative Light Units (RLUs) were measured with a 
chemiluminometer (Lumat LB9507, EG&G Berthold, Germany). The total protein was 
measured according to a BCA protein assay kit (Pierce), and the luciferase activity was 
expressed as RLU/mg protein. 
2.7. Structural characterization of the pDNA/CL complexes using Synchrotron 
SAXS  
Structural information, such as the bilayer electronic density profile (EDP) and 
bilayer-bilayer distance, was obtained via small angle x-ray scattering (SAXS) analysis. 
The SAXS experiments were performed at the SAXS1 beamline at the Brazilian 
Capítulo 3 
61 
 
Synchrotron Light National Lab (LNLS) using a beam energy of 8 keV (=1.55 Å) and 
sample-to-detector distance of 561 mm. The measured intensity is displayed as a 
function of the reciprocal space momentum transfer modulus q=4 sin() / , where 2 is 
the scattering angle, and  is the radiation wavelength. The typical q range was from 
0.017 Å-1 to 0.45 Å-1. 
The dispersion of the liposomes exhibits a liquid-crystalline character and can be 
considered as presenting a form factor, P(q), related to the electronic density profile 
(EDP) across the lipid bilayer and a structure factor, S(q), related to the periodicity of the 
lipid bilayer. Therefore, the scattering intensity I(q) can be expressed as follows:  
 )()()( qSqPqI               (Equation 1) 
This procedure is known as the decoupling method and assumes that in the 
intensity formulation, the form factor and the structure factor can be treated separately. 
The model used for the form factor and the optimization method are described 
elsewhere [32, 33]. For the structure factor, a model based on the Modified Caillé 
Theory (MCT) was used, permitting a proper description of the structure factor for 
lamellar systems.  
3. Results 
3.1. Physicochemical characterization of pDNA/CL complexes   
pDNA/CL complexes were obtained at different molar charge ratios (R+/-) and 
their number-weighted mean diameter, polydispersity index and zeta potential profiles 
as a function of R+/- are presented in Figure 1. Similar profiles can be observed for the 
number-weighted mean diameter and polydispersity index (Figures 1A and 1B, 
respectively). The greatest mean diameter was approximately 500 nm, and the highest 
polydispersity index was 0.5. These high values correspond to the isoneutrality region, 
where the R+/- values are close to 1. With increasing R+/- values (decreasing the 
proportion of DNA and increasing the lipid content), the mean diameter and 
polydispersity index decrease until the liposome properties are achieved (diameter of 
100 nm and a polydispersity index of 0.1). The zeta potential profile has a sigmoidal 
shape, as expected based on previously reported results for other lipid complexes [15, 
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34, 35] (Figure 1 C). This trend shows three different zeta potential regions: (i) a region 
where the negative net charge of the complex is close to the plasmid DNA net charge (ζ 
= 52.2 ± 6.1 mV); (ii) an isoneutrality region, where inversion of the zeta potential sign 
takes place (approx. R+/- 1); and (iii) a region where the net charge of the complexes is 
positive, tending toward the value of empty liposomes (ζ = 60.8 ± 1.7 mV). 
 
Figure 1.  Number-weighted hydrodynamic mean diameter (A), polydispersity index (B) and 
zeta potential (C) profiles of pDNA/CL complexes at different molar charge ratios (R+/-). The solid 
lines are a visual guide to better demonstrate the trend of the variations. The error bars 
represent the standard error of independent triplicates.  
From the profiles shown in Figure 1, four different R+/- values (1.8, 3, 6 and 9) 
were selected for further investigation based on the number and volume-weighted size 
distributions (Figure 2). The selection of R+/- values was based on pDNA/CL complexes 
with a positive zeta potential, which is the minimal condition for transfection experiments 
in the absence of any specific mechanism for transfection [36]. Both size distributions 
were investigated because the volume-weighted size is more sensitive to the presence 
of small fractions of a population with larger sizes. Additionally, the intensity of scattered 
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light is proportional to the diameter raised to the sixth power, and number-weighted 
mean diameter presents the distribution profile in terms of most numerous (relevant) 
population (the intensity of scattered light is proportional to the number of particles) [37]. 
 
Figure 2. Number (A) and volume-weighted (B) size distribution of pDNA/CL complexes at R+/- 
values of 1.8, 3, 6 and 9. “Empty” cationic liposomes are presented for comparison. The lines in 
each size distribution represent the profile of three independent pDNA/CL complexes. 
The volume-weighted size distribution (Figure 2B) shows that with increasing 
amounts of DNA (decreasing R+/-), there is a slight increase in the width of the size 
distribution, and at R+/-=1.8, a second population arises with a diameter of approx. 5 m. 
However, when the number-weighted size distribution is analyzed (Figure 2A), only one 
population is found at R+/-=1.8 (being the most abundant). These nuances in the size 
range may suggest structural changes induced by the proportion of DNA in cationic 
liposomes and the presence of groups with different structural organizations. 
The ability of cationic liposomes to incorporate pDNA into their structure was 
evaluated via a gel retardation assay at different R+/- values (Figure 3). Free pDNA 
migrates out of the well towards the positive pole, giving rise to two bands: the high-
mobility band represents the most compact (super-coiled) form, while the less-intense 
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band is considered to represent the non-super-coiled form. The pDNA/CL molar charge 
ratio (R+/-) that results in complete retention of the DNA in the lipid structure is 1.5 
(Figure 3). 
 
Figure 3. Gel retardation assay. One microgram of pDNA was complexed with CL at different 
positive/negative molar charge ratios (R+/-) in PBS. 
The morphology of “empty” CL and pDNA/CL complexes at R+/-=3 were evaluated 
by transmission electron microscopy (TEM) using a negative staining technique (Figure 
4). The “empty” CL (Figure 4A and B) has a rather spherical shape with a diameter of 
~130 nm (Figure 4B). Isolated liposomes can be observed without evidence of 
aggregation and/or fusion. As summarized in Figure 4 C and D, aggregates are 
observed in the presence of DNA. Due to this phenomenon, the pDNA/CL complexes 
(Figure 4C and D) exhibit polymorphic characteristics and a different volume-weighted 
size distribution (Figure 2B) when compared to empty liposomes (Figure 4A and B). It is 
also possible to identify some deformation in the spheroidal shape of the complexes and 
aggregation of vesicles.  
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Figure 4. Negative staining electron micrographs of “empty” cationic liposomes (CL) (A and B) 
and pDNA/CL complexes at a molar charge ratio of R+/-=3 (C and D). Scale bars indicate 100 
nm in (A, B and C) and 200 nm in (D). 
 
3.2. In vitro transfection of HeLa cells 
The ability of EPC/DOPE/DOTAP liposomes complexed with DNA to transfect 
HeLa cells in vitro was examined based on the previous physicochemical 
characterization (Figure 5). It can be observed that when R+/- decreases from 10.2 to 3, 
there is an increase in luciferase activity, indicating an increase in the transfection level. 
However, the transfection level decreases at an R+/- value of 1.8. In this context, R+/-=3 - 
6 is the best range for in vitro transfection of HeLa cell using the lipids 
EPC/DOTAP/DOPE (50:25:25% molar ratio). 
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Figure 5. In vitro efficacy of HeLa cell transfection using pDNA/CL complexes at different molar 
charge ratios (R+/-); the plasmid pVAXLUC contains a luciferase reporter gene under the control 
of the CMV promoter. Luciferase activity was expressed in RLU/mg protein. “Naked” pDNA and 
Lipofectamine (negative and positive controls) are shown in the inset graph. The error bars 
represent the standard error of triplicates. * p < 0.05 was considered statistically different 
compared to other samples, except at R+/-=6. NS, not significant. 
We used the commercial transfection reagent Lipofectamine® as a positive 
control and naked plasmidal DNA as a negative control. Figure 5 (inset graph) shows 
that when naked DNA was used, there was no (or very low) transfection. When the 
positive control (Lipofectamine®) was used, higher transfection levels were achieved 
compared to those obtained with pDNA/LC at R+/-=3.  
3.3. In vitro cytotoxicity 
To determine whether the CL comprised of the investigated lipids have an effect 
on HeLa cell death, we assessed cell viability after treatment with pDNA/CL complexes, 
the commercial transfection reagent Lipofectamine® and “naked” pDNA (Figure 6). Free 
pVAX-LUC did not show any effects on cell viability. Similar results were found for the 
pDNA/CL complexes at all of the examined molar charge ratios (R+/-). However, the 
Lipofectamine transfection reagent significantly decreased cell viability by approx. 30%, 
indicating a higher cytotoxicity level. 
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Figure 6. Cell viability assay of pDNA/CL complexes in HeLa cells. Lipofectamine and pDNA 
were used as controls. Data are presented as the mean ± SD of six experiments. * p < 0.05 was 
considered statistically different. 
3.4. Structural characterization of the pDNA/CL complexes using Synchrotron 
SAXS 
 The small angle x-ray scattering intensities of four molar charge ratios (R+/-=1.8, 
3, 6 and 9), previously studied in in vitro transfections, were measured for comparison 
with the reference “empty” liposome. Figure8 shows the scattering curves for all 5 
systems. The “empty liposome” presents a typical scattering profile for a unilamellar 
vesicle system. It can be observed that the scattering curves for all of the pDNA/CL 
complexes show correlation peaks, which we will later associate with a fraction of the 
system exhibiting multilamellar order. As the molar charge ratio (R+/-) decreases 
(increased pDNA amounts), the correlation peaks become more pronounced, showing 
the great contribution of the structure factor for large amounts of DNA into the system.  
The scattering vector range achieved in our SAXS experiment is able to provide 
reasonable information about the membrane bilayer and long range ordering. This 
information can be obtained from a proper modeling of the scattering data using two 
terms: (1) the form factor, which carries information about the shape of the bilayer and 
its electronic contrast, and (2) the structure factor, which provides information about 
system periodicity, membrane rigidity, fluctuation and the average number of correlated 
layers. We described the form factor as a sum of equally spaced Gaussian functions, 
which simulates the electronic density profile (EDP) across the lipid bilayer, and we used 
the Modified Caillé structure factor to simulate bilayer stacking [32, 33]. 
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Figure 7. Small angle x-ray scattering intensity for “empty” liposomes and pDNA/CL complexes 
at four different molar charge ratios (R+/-) with the respective fitting curves.  
We proposed two different models to fit the scattered intensity. As a first attempt, 
the scattering curves were fitted using a single form factor for each of four different 
molar charge ratio (R+/-) systems. Additionally, it was assumed that the system can be 
composed of two phases: a fraction of unilamellar vesicles and a fraction of multilamellar 
vesicles. In this approach, the scattered intensity I(q) is written as  
 
)()()( qSqPqI eff                                        (Equation 2) 
where Seff(q)=fsb+fmSMCT(q), in which fsb is a constant related to the fraction of single 
bilayers; fm gives the relative fraction of multilayers; and SMCT(q) is the Modified Caillé 
structure factor. This model fits the data reasonably well for R+/-=9, 6 and 3 but gives a 
poor fit for the R+/-=1.8 scattering curve (data not shown). An interesting result from this 
first step was that the average number of correlated bilayers, N, was always ~2 when 
R+/- was 9, 6 or 3. This finding strongly indicates the formation of double bilayers (rather 
than triple or other multiples), which may suggest the existence of domains such as 
juxtaposed neighbor unilamellar liposomes. These domains were previously observed 
using electron microscopy [38, 39], where it was found that juxtaposed double bilayers 
could even exist in large aggregates composed of several liposomes. Another 
interesting result was that the convergence of the fitting was only achieved after allowing 
superposition between the last Gaussian function of the bilayer EDP in the double 
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bilayer phase model. Although on first glance, this superposition may oddly suggest an 
overlap of head groups, it can actually represent the average electronic density of the 
DNA inserted between consecutive bilayers.  
The main limitation of this first approach was the use of a single bilayer profile to 
describe the system. Therefore, a more sophisticated model was proposed enabling the 
use of multiple bilayer sizes and shapes. In this new approach, the system is composed 
of two phases: (1) a single bilayer and (2) a double bilayer bounded by DNA between 
two consecutive bilayers. In this model, we fit all of the curves presented in Figure 8 
simultaneously. This model enabled better fitting of the scattering data because it allows 
differences among the electron density profiles for a single bilayer and a double bilayer 
(where the DNA is inserted). As will be discussed below, several assumptions were 
made to decrease the number of fitting parameters. This model was supported by the 
results of the complementary techniques that we used previously: (1) the Zeta potential 
assured that there would be no DNA on the external surface of the liposome, as shown 
in Figure 1C; (2) the gel retardation assay ensured that we would not observe free DNA 
on the water, as seen in Figure 3; (3) the TEM images suggested the existence of 
agglomerates such as juxtaposed liposomes with a double bilayer at the interface; and 
(4) the DLS results demonstrated a slight distortion of the volume-weighted size 
distribution, suggesting larger aggregates associated with increases in DNA, as seen in 
Figure 2B. Moreover, the TEM images shown in the works of Huebner et al., [38] and 
Angelov et al. [40] indicate that the pDNA/CL lipoplexes are composed mainly of single 
and double bilayers, despite the fact that multibilayers can still be found.  
Figure 8 shows that the R+/-=1.8 scattering curve presents sharp correlation 
peaks, characteristic of a periodic structure, in addition to the scattering from double and 
single bilayer phases. Therefore, a new phase composed of several bilayers was added 
to the model. This effect could be a contribution of aggregates formed by liposomes that 
might have been fragmented and stacked, as proposed by Barrileiro et al., [41, 42] and 
Hueber et al. [38].  
The scattered intensity using this model was given as follows: 
 )()()()()()( qSqPfqSqPfqPfNqI mmmdddssSC                       (Equation 3) 
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where the subscripts s, d and m indicate the single, double and multiple bilayer phases, 
respectively; f represents the relative phase fraction of each system (fm is zero for R+/-=9, 
6 and 3); P(q) is the form factor; S(q) is the Modified Caillé structure factor; and Nsc is an 
overall scaling constant. To decrease the number of fit parameters and permit 
convergence of the fitting procedure, a number of assumptions were made: The form 
factor for the double and multiple bilayers were considered to be the same 
(Pd(q)=Pm(q)), but they could be different from the single bilayer form factor. As 
suggested by the first model step, the changes in the form factor were obtained through 
the inclusion of an extra Gaussian function between consecutive bilayers to represent 
the DNA electronic density. This change was sufficient to represent both the double 
bilayer and the multiple bilayer phases. The electronic density profile obtained for the 
three phases is shown in Figure 8.  
 
Figure 8. Electronic density profile across the lipid membrane for three different phases resulting 
from modeling and fitting of SAXS data. 
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Certain parameters related to the Structure factor also had to be fixed to permit 
model convergence after studying the influence of each parameter in the scattering 
intensity. The Caillé parameter, for example, had a small influence on the scattering 
intensities for the double bilayer phase and was fixed at zero. It was possible to observe 
that when this parameter is greater than 0.05, the peak in the simulated curve for all R+/- 
values located at Q~0.37 Å-1 disappears, which indicates that this parameter should be 
lower than that value. For the multiple bilayer phase, there is greater precision in the 
determination of the Caillé parameter. The value obtained was 0.080.02, indicating a 
decrease in membrane rigidity in comparison with the double bilayer, which is probably 
induced by the fragmentation and stacking of bilayers above a critical concentration of 
pDNA. In all cases, the periodicity, which is the size of bilayer plus water layer between 
two consecutive bilayers, was close to 66 Å. The number of bilayers, N, was let as a free 
parameter only in the multiple bilayer phase, when it was found to be around N=5.2. The 
fitting parameters are shown in Table 1. 
Table 1. Parameters obtained from simultaneous fitting of all scattering curves. 
 Phases 
Parameters single bilayer double bilayer multiple bilayer 
fraction of R+/- 1.8 0.28  0.05 0.51  0.05 0.20  0.02 
fraction of R+/- 3 0.69  0.04 0.31  0.04 na** 
fraction of R+/- 6 0.87  0.01 0.13  0.01 na** 
fraction of R+/- 9 0.92  0.01 0.08  0.01 na** 
Number of bilayers (N) 1* 2* 5.2  0.5 
Caillé parameter () na** < 0.05 0.08  0.02 
Periodicity (D, in Å)  na** 66.2  0.2 66.6  0.2 
*fixed parameter; **not applied. 
Summarizing the results from the SAXS experiments, we found three 
independent phases: the single, double and multiple bilayer phases. These phases can 
be understood to correspond to empty unilamellar liposomes, juxtaposed neighbor 
liposomes bounded by a pDNA layer and large aggregates formed by stacked bilayers, 
also bounded by pDNA layers. 
The fs, fb and fm fractions were obtained from the model results. The form factor of 
each phase is normalized to 1 and the fractions satisfy the constraint fd+fb+fm=1. 
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Although there are several other procedures for normalization and fraction estimation, 
this procedure at least provides the relative trend of each contribution. The results, as 
shown in Figure 9, are an indication of the evolution of the phases, suggesting an 
increase in the double bilayer phase as a function of pDNA complexation. We also 
observe a saturation point between the molar ratios 1.8<R+/-<3, where the aggregates 
with multiple bilayers start to appear. 
 
Figure 9. Phase partitioning for all of the studied systems. The largest amount of pDNA added 
to the system generates a ternary phase system with single, double and multiple bilayers. 
4. Discussion 
Cationic liposomes composed of EPC/DOTAP/DOPE were initially studied as 
dehydrated-rehydrated vesicles (DRVs) for conventional encapsulation of pRc/CMV 
HBS DNA (encoding the small region of the hepatitis B surface antigen) [27]. Later, the 
viability of EPC/DOTAP/DOPE-DRVs surface complexed with DNAhsp65 for the 
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administration of a single dose tuberculosis vaccine [25, 26], and tuberculosis treatment 
[2] was demonstrated in vivo. Different researchers have evaluated the use of cationic 
liposomes containing the same lipid composition focusing on different production 
methods [43] and on in vitro cell viability [44]. 
Considering the previous successful in vivo studies, the current work was focused 
on the in vitro evaluation of EPC/DOTAP/DOPE liposomes with the same lipid 
composition studied earlier. Because DRV structures present a complex size distribution 
[25, 26], the behavior of these liposomes was investigated at a controlled size to obtain 
a proper understanding of the pDNA/CL association. The conventional protocol based 
on the hydration of dried film method followed by extrusion was employed. Using this 
procedure, it was possible to produce CLs with a diameter of 100 nm, polydispersity 
index of 0.1 and zeta potential of 60 mV (Figure 1). The plasmid DNA model used, 
pVAX-Luc, encode a luciferase reporter gene, enabling easy assessment of transfection 
efficiency. 
The initial step in the investigation of the pDNA/CL complexes focused on 
conventional physicochemical characterization, aimed at identification of the proper 
conditions for in vitro transfection analyses. Here, the mean hydrodynamic diameter 
(number-weighted), polydispersity index (PdI) and zeta potential profiles were evaluated 
as a function of the cationic/anionic molar charge ratio between cationic lipids and DNA 
(R+/-). It was observed that R+/- values higher than 1.5 represent the ideal range for the 
investigation of in vitro transfection, as the mean diameter and PdI are less than 200 nm 
and 0.25, respectively, and the zeta potential assumes positive values (Figure 1). At R+/-
=3 or higher, the average diameter and PdI tend to stabilize near the values of “empty” 
CL (Figures 1A and B). The gel retardation assay confirmed the physicochemical 
characterization, showing that at R+/- values higher than 1.5, all of the pDNA is retained 
(Figure 3) as a consequence of DNA condensation into the lipid structure. These results 
are in good agreement with those of previous studies involving 
DNAhsp65/DOTAP/DOPE liposomes [25]. 
Based on the physicochemical characterization, we strategically selected some 
pDNA/CL complexes at R+/- values ranging from 1.8 to 10.2 to evaluate variations in the 
size distribution (Figure 2) and the level of transfection (Figure 5) and to study liposome 
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structural modification as a function of R+/- (Figure 7), with the aim of determining the 
correlation between these properties.  
In the in vitro studies, we observed a significant influence of R+/- on the 
transfection level (Figure 5). An R+/- value of 10.2 was associated with the lowest 
transfection level; when R+/- was 3 or 6, the transfection levels were statistically equal, 
and these values represented the best conditions for achieving higher luciferase 
expression (Figure 5), confirming that R+/- is an important parameter to be considered in 
the development of pDNA/CL complexes. These results are in agreement with those of 
other published studies. Candiani and co-workers [45] found that maximum transfection 
levels were achieved at a molar charge ratio of 5, and the transfection levels decreased 
when R+/- was decreased until reaching 1.25 and increased until R+/-reached 15. The 
lipid composition investigated by Candiani et al. [45] (DOPC/DOPE with different 
surfactants) was also shown to be more susceptible to size and polydispersity variations 
in the presence of pDNA compared to our lipid composition. Similar trends were 
observed by Masotti and co-workers [46], who investigated several commercially 
available transfection agents at various R+/- values. 
To understand the variation in the transfection results as a function of different 
R+/- values, our initial approach was comparison of the physicochemical properties of 
these complexes. All of the tested pDNA/CL complexes exhibited a positive zeta 
potential (Figure 1A), and all of the pDNA was incorporated into the lipid structure 
(Figure 3). When we examined the number and volume-weighted size distribution 
(Figure 2) and PdI, it was found that R+/- values ranging from 3 to 9 resulted in similar 
profiles. Differences can be observed at R+/-=1.8, which is a pDNA/CL ratio close to the 
isoneutrality region. However, R+/-=10.2 was associated with a controllable diameter, PdI 
and zeta potential close to the values for “empty” liposomes (Figure 1). Considering only 
the physicochemical results, we concluded that there was not sufficient information to 
elucidate the influence of the pDNA/CL complexes on in vitro HeLa cell transfection. 
The cationic liposomes examined in the present study were composed of three 
different lipids. Most of the reported studies have used cationic liposomes composed of 
only two lipids: one with cationic characteristics (e.g., DC-Chol, DOTMA or DOTAP) and 
another with neutral characteristics (e.g., DOPE or DOPC). Stegmann & Legendre [47], 
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who employed lipid compositions of DOTAP/DOPE and DOTMA/DOPE, and Congiu and 
co-workers [22], who employed the lipid composition DC-Chol/DOPE, reported no 
correlations between the obtained transfection results and physicochemical properties 
such as size, zeta potential and lipid mixing. Another study examining the lipid 
compositions DOTAP/DOPE and DOTAP/DOPC reported an influence of lamellarity and 
the pDNA/CL preparation method on transfection efficiency [48].  
Thus, the presence of the third EPC in the present work reflects a difference 
compared to previously reported studies. To improve our understanding of the pDNA/CL 
complexes, we carried out SAXS experiments to examine the structural properties of the 
complexes (Figure 7). For the selected R+/- values, ranging from 1.8 to 9, we observed 
that complexation with DNA contributes to increasing the number of double bilayers in 
the system, as if the pDNA plays the role of an electrostatic adhesive between two 
unilamellar neighbor liposomes, which corroborates the TEM image analysis (Figure 4), 
providing further evidence supporting the formation of aggregates of juxtaposed 
unilamellar liposomes. If more than two vesicles are juxtaposed, the final volume of the 
aggregate will be very large, but the number of correlated bilayers, N, is still 
approximately 2 because of the double bilayer in the interface between neighboring 
vesicles. According to the results presented herein, double bilayers appear to provide 
the ideal structure for DNA storage for later efficient transfection. 
Close to the isoneutrality region, at R+/- ~1.8, it was determined that a 
considerable fraction of the system had an average of 5 bilayer domains. These 
domains, together with the liposome stacking promoted by the pDNA, significantly 
increase the size of the aggregates, as confirmed by DLS measurements weighted by 
volume (Figure 2). 
This event was also confirmed by TEM images (Figure 4) showing a significant 
change in the morphology of the complex compared to liposomes without pDNA. 
Huebner et al. [38] employed the lipid composition DMPC/DC-Chol and reported 
morphological changes in the liposomes in contact with DNA. They also observed the 
formation of clusters of DNA-coated unilamellar vesicles and flattening of the bilayers at 
the contact regions of adjacent vesicles, forming particle aggregates. 
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This rapid structural change close to the isoneutrality region is supported by the 
ability of the lipid EPC to maintain the liposomal structure in the presence of pDNA, as 
we did not observe an inverse hexagonal phase (HCII) at any of the studied R+/- values. 
This behavior is a consequence of the presence of EPC at a  50% molar ratio in the 
liposome composition [49]. Additionally, the complexation process was carried out under 
a controlled temperature (ice bath), which decreases the velocity of the electrostatic 
reaction, allowing the formation of more organized structures [50, 51]. Close to the 
isoneutrality region, an excess of pDNA may induce saturation of the vesicles regarding 
retaining pDNA in their bilayers, generating new structures showing greater numbers of 
bilayers and fusion of aggregates of particles, which does not appear to be efficient for 
later release processes or transfection. 
Considering the characteristics presented above, the pDNA/CL complexes 
present two different types of structural configuration, dependent on R+/-. The first type 
presents only controllable structures with double bilayers, which are increased with 
increases in the amount of DNA (or decreasing values of R+/-). This finding explains the 
transfection differences observed for R+/-=9 compared with R+/-=3 or 6. All of the wells 
were transfected with amounts of pDNA per well that were statistically equal, which 
means that different amount of lipids were used. Taking previous findings into account, 
the electrostatic complexation between pDNA and CL was controlled, and the difference 
between these complexes is the proportion of double bilayers formed based on the 
presence of pDNA and the lipid content, which can be related to the number of vesicles. 
This suggests that in the case of R+/-=10.2, there will be an excess of “empty” liposomes, 
which will compete with the pDNA/CL complexes for cell internalization, resulting in a 
lower level of transfection (Figure 5). When R+/- is decreased from 9 to 3, the proportion 
of bilayers is increased, and the number of “empty” liposomes is decreased (lower 
competition for cell incorporation). In this case, the transfection level is increased with 
decreases in R+/-, reaching a maximum level at R+/-=3 (Figure 5). When R+/- is 1.8, there 
is an excess of DNA, allowing the formation of aggregates with multiple bilayers. The 
elevated number of bilayers probably provides additional resistance to the release of 
pDNA inside the cells and adds to the effect of the increase in the size of the complex, 
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explaining the decrease in the transfection level. Figure 9B is a schematic diagram 
demonstrating the relationship between R+/- and the described complexation process. 
Additionally, comparison of this lipid composition with Lipofectamine and “naked” 
pDNA regarding the transfection of HeLa cells confirmed the viability of these lipids for 
gene delivery applications (Figure 6). Despite presenting a better transfection efficiency 
compared to other cationic lipids, Lipofectamine is much more cytotoxic. It is well-known 
that the cell death induced by cationic lipids is mainly caused through apoptosis [52], 
and multivalent cationic lipids (i.e., DOSPA, present in lipofectamine) are more toxic 
than monovalent cationic lipids (i.e., DOTAP) [53]. The ~30% decrease in cell viability 
shows the non-feasibility of using this commercial transfection reagent for in vivo 
applications. Reza et al. [54] also reported a reduction of 30% in cell viability induced by 
lipofectamine in Chinese hamster ovary cells. Furthermore, de la Torre et al. [25] 
showed that by using EPC in the liposomal composition, the cytotoxicity to the J744 
macrophage cell line was significantly decreased, which also supports the potential 
applications of this formulation. 
5. Conclusions 
In conclusion, in this study, it was possible to verify that different molar charge 
ratios had a significant impact on the numbers of lamellae and, consequently, on the 
structural conformation of the complexes. These structural changes in the pDNA/CL 
complexes resulted in different transfection levels. Despite this relationship, at R+/- 
values from 1.5 up to 9, the physicochemical properties of the complexes were nearly 
unaffected in terms of the number-weighted particle size, polydispersity and zeta 
potential. However, as the present SAXS analyses showed structural changes in the 
complexes at R+/-=1.8, we could investigate these changes by screening the DLS 
measurements weighted by volume. We believe that the results presented here 
contribute to the understanding and correlation of the physicochemical and structural 
properties of pDNA/cationic liposome complexes with the associated transfection 
phenomenon, aimed at rational design of future nonviral gene vectors. 
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Abstract 
 Microfluidics is a powerful technology that allows the production of cationic 
liposomes by the hydrodynamic focusing method. We first studied a single 
hydrodynamic focusing (SHF) device, which uses a central stream in which lipids 
dispersed in ethanol are injected and hydrodynamically compressed by the two 
aqueous streams. The ethanol diffusion from the inner stream to the aqueous 
stream encourages the formation of the liposomes. To intensify the mass diffusion 
and increase the surface area between the two fluids, a second device was 
designed with double hydrodynamic focusing (DHF). We investigated the influence 
of Fluid Flow Velocity (Vf), Flow Rate Ratio (FRR) and Total Lipid Concentration 
(Clip) on the particle size of the CLs produced. The DHF microfluidic device had the 
ability of using higher Vf values than the SHF device, which resulted in a higher 
productivity level. Small Angle X-ray Scattering (SAXS) experiments were 
performed to structurally characterize the cationic liposomes produced by both 
microfluidic devices. The SAXS results revealed that both devices produce 
unilamellar cationic liposomes with a very small fraction of multilamellar liposomes; 
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this finding is in agreement with the observations made in the analysis of the 
liposomes using Transmission Electron Microscopy (TEM). The biological 
efficacies of the cationic liposomes produced by both microfluidic devices were 
examined in vitro in HeLa cells, which confirmed their potential for gene delivery 
and vaccine therapy applications.  
1.  Introduction 
Liposomes are amphiphilic lipid systems that, in aqueous media, self-
assemble into spherical bilayers with an aqueous interior lumen. They are 
generally formed because the lipid association yields entropically favorable states 
of low free energy in an energetically favorable manner [1]. Their biochemical 
structure is very similar to that of human cell membranes. Cationic lipids can form 
an electrostatic complex with DNA, which can then be efficiently delivered to the 
cell nucleus [2]. This feature makes cationic liposomes (CL) a promising gene 
delivery system for medical applications in the fields of vaccine and gene therapy 
[3].  
Despite the longstanding interest in liposomes, especially cationic 
liposomes, only a small number of liposomal products have been approved for 
human application. This may be due to the lack of techniques that can produce 
liposomes efficiently and with a relatively low cost on an industrial scale. 
Furthermore, it is necessary to meet the requirements of the pharmaceutical 
industry, such as sterilization, when producing products for human use [4]. The 
majority of the current techniques used for liposome production require a unit 
operation step for the size reduction and homogenization of the particles. The most 
common post-processing methods are sonication [5, 6], extrusion [7] and high 
pressure homogenization [8]. Recent approaches in the field of liposome 
production aim to develop techniques that decrease the number of steps and time-
consuming processes involved in the current production protocols [9].  
The use of microfluidic systems in liposome production might overcome 
these major challenges. Microfluidics is a powerful technology that manipulates 
minute volumes of fluids (10-9 to 10-18 liters) inside channels with dimensions in the 
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order of micrometers. Therefore, microfluidic systems are able to control 
concentrations of molecules in space and time [10]. A number of different 
microfluidic approaches have been employed in liposome production. The 
sequential infusion of water, oil that contains lipids and water into the main channel 
results in the formation of bilayer lipid membranes on chambers that are located on 
the walls of the main channel. These chambers, which were pneumatically driven 
by valves, allowed the formation of liposomes [11]. In addition, a microfluidic 3D 
flow focusing device with a modified surface was shown to control the immiscible 
flows, in which, after solvent extraction, double emulsion templates could be 
transformed into liposomes [12].  
Another simple microfluidic strategy for liposome production, which was 
developed by Jahn and co-workers [13-15], used a hydrodynamic focusing (MHF) 
method to control the liposome formation with particle sizes ranging from 50 to 500 
nm by improving the classical alcohol injection. The liposomes were composed of 
dimyristoylphosphatidylcholine, cholesterol and dihexadecyl phosphate. This 
technique uses a microfluidic device with a four-microchannel intersection 
geometry and an organic solvent (isopropanol) with dispersed lipids. The lipid-
dispersed solution is injected into the middle stream, where it is hydrodynamically 
compressed by two aqueous (or buffered) streams. The control of the Flow Rate 
Ratio (FRR) between the aqueous and organic streams and the Total Volumetric 
Flow Rate (Qt) in the outlet stream allows the ethanol and aqueous streams to mix 
through molecular diffusion influenced by convection, resulting in the self-assembly 
of phospholipids into liposomes. In the reported studies, the lipid content of the 
liposomal formulations obtained by the microfluidic devices ranged between 0.1 
and 0.4 mM. Therefore, the size particle homogenization post-processing step is 
not required, which results in a simpler liposome production protocol that can be 
used for personalized medicine applications, such as gene and vaccine therapy. 
Furthermore, the potential on-chip liposome production at the point of care would 
facilitate the therapeutic treatment, minimizing the amount of lipid oxidation and 
degradation.  
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Recently, our research group developed a cationic liposome formulation 
(EPC/DOTAP/DOPE 50:25:25% molar) that complexes with DNAhsp65 for use in 
the tuberculosis vaccine and treatment. The liposome was produced using the 
conventional method at the laboratory scale and exhibited a high lipid content with 
a concentration of extruded liposomes of 16 mM [7, 16-18]. The necessity of 
liposome production methods that can yield liposomes with high lipid contents that 
can be further tested in vivo and in vitro has led our group to search for new 
production strategies.   
The potential of microfluidics and the lack of studies that use microfluidic 
devices for the production of cationic liposomes led us to study the production of 
CL, which is useful for gene delivery at the same lipid composition that we 
achieved in the tuberculosis gene vaccine and therapy, through two 
methodologies: (i) single hydrodynamic focusing (SHF), which is based on the 
work of Jahn and co-workers [13-15], and (ii) double hydrodynamic focusing 
(DHF), which was designed to intensify the mass diffusion by increasing the 
diffusion surface area and thus the productivity of the CL formulations. We 
optimized the production of CL by both microfluidic devices using Central 
Composite Rotatable Designs. We also studied the effect of the following 
parameters: Flow Rate Ratio (FRR), Average Fluid Flow Velocities (Vf) and Total 
Lipid Content (Clip). In addition, to evaluate the biological viability of the CL 
formulations produced, we assayed their transfection ability in human epithelial 
carcinoma (HeLa) cells in vitro. In this manuscript, we show the feasibility of using 
these two microfluidic devices for the high yield production of CLs with suitable 
characteristics for gene delivery and vaccine therapy.  
2. Materials and Methods 
2.1. Materials 
The lipids were composed of egg phosphatidylcholine (EPC), 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) (50/25/25% molar). All the lipids were 
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obtained from Lipoid and were not purified further. We used absolute ethanol from 
Sigma Chemical Co. 
2.2. Cationic Liposome Production 
The CL production was carried out in two hydrodynamic flow focusing 
microfluidic devices, which are illustrated in Figure 1. The lipids, which were 
dispersed in ethanol in the proportion that was previously described [16-18], were 
loaded into a 1 mL glass syringe. Deionized water was loaded into two 3 mL glass 
syringes. Infusion syringe pumps (Kd Scientific, model 200, USA) were used to 
control the flow of each solution into the inlet channels. In the Single Hydrodynamic 
Focusing (SHF) microfluidic device (Figure 1A), the lipid dispersion in ethanol flows 
through the center inlet channel and the deionized water flows through the two side 
inlet channels and hydrodynamically compresses the middle stream. The Double 
Hydrodynamic Focusing (DHF) microfluidic device (Figure 1B) had two consecutive 
flow focusing regions, which increase the diffusion surface area between the 
organic and the aqueous streams. Both devices were designed in AutoCAD 
(Autodesk). All channels, which had a rectangular cross section with a depth of 100 
m and a width of 140 m,  were constructed using soft lithography in 
polydimethylsiloxane (PDMS) and bounded to glass through O2 plasma surface 
activation, as described elsewhere [19]. The flow rates of the streams were 
adjusted to control the degree of hydrodynamic focusing and the width of the 
center stream, thus controlling the liposome formation. 
The Flow Rate Ratio (FRR) is defined as the ratio of the volumetric aqueous 
flow rate to the volumetric flow rate of the lipid dispersion in ethanol. The 
microfluidic production of CL by both devices was examined at various FRRs, 
Average Fluid Flow Velocities at the device outlet (Vf) and Total Lipid 
Concentrations (Clip) in the lipid dispersion. The stability of the focusing region was 
observed at 40x magnification under a trinocular stereo microscope (Bell 
Engineering, Italy). The liposome samples were collected at the microfluidic device 
outlet for subsequent analysis. 
Capítulo 4 
88 
 
The CLs used in the in vitro assays were produced under sterilized 
conditions prior to experimentation by using sterile syringes and collected in sterile 
conical centrifuge tubes. The microfluidic devices were carefully washed with 
ethanol (70% v/v) and dried with nitrogen pressure prior to use. 
 
Figure 1. Microfluidic devices with single (A) and double (B) hydrodynamic focusing with a 
Total Lipid Concentration of 25 mM dispersed in ethanol, a Fluid Flow Velocity of 143 
mm/s and a Flow Rate Ratio of 10. 
To evaluate the biological applications of the liposomes produced by the 
microfluidic methods, the CLs were also prepared using a bulk method described 
elsewhere [20] under sterile conditions. This method, which is called the thin film 
method, required that all lipids be dispersed in chloroform and the required 
amounts of the stock solutions (EPC/DOPE/DOTAP 50/25/25% molar) were mixed 
and dried to produce a thin film using a rotary evaporator in a 650 mmHg vacuum 
for 1 hour. The dried lipid film was then hydrated with water to a final lipid 
concentration of 16 mM. The prepared liposomes were extruded through double 
polycarbonate membranes with a 100 nm nominal diameter under a nitrogen 
pressure of 12 kgf/cm²; this extrusion step was repeated 15 times. 
A 
B 
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2.3. Physicochemical and structural characterization 
2.3.1. Average hydrodynamic diameter and Polydispersity 
The dynamic light scattering (DLS) technique was used to measure the size 
distribution, polydispersity and the average hydrodynamic diameter using a 
Zetasizer Nano ZS (Malvern) with a backscattering detection angle of 173°, a 
He/Ne laser that emits at 633 nm, and a 4.0 mW power source. The average 
hydrodynamic diameter, or Z-average size, was weighted by the intensity of the 
scattering in the DLS. The mean particle size was obtained from the results of 
three experiments. The size distribution was evaluated with the polydispersity 
index. This index ranges from 0 to 1; the lower values indicate more a 
homogeneous distribution of the particle sizes. In addition, the polydispersity index 
was calculated from analysis of the cumulants of the DLS-measured intensity 
autocorrelation function. The CONTIN algorithm, which is based on an inverse 
Laplace transform in the autocorrelation function, was used to estimate the 
average diameter and polydispersity index of the particle sizes. All the samples 
were diluted to 0.2 mM prior to the analysis. 
2.3.2. Zeta Potential Measurement 
The zeta potential of the samples was measured by applying an electric field 
across the samples, and the zeta potential value was obtained by measuring the 
electrophoretic mobility of the particles using the Laser Doppler Anemometry 
technique. The measurements for each sample were performed in triplicate in 
water at 25 °C using a Malvern Zetasizer 3000 (Malvern).  
2.3.3. Morphology  
The liposomes produced by the two microfluidic devices were imaged to 
verify their morphology by means of Transmission Electron Microscopy (TEM) and 
the negative staining method. A drop of the samples (~5 L) was placed on a 
copper grid coated with a carbon film. The excess liquid was removed with blotting 
paper, leaving a thin film stretched over the grid. The negative staining was 
performed with a 2% solution of ammonium molybdate for ~10 s and then blotted 
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dry. The electron microscopy was performed using a LEO 906E microscope (Zeiss, 
Germany) at 80 kV, the MEGA VIEW III/Olympus camera and the ITEM E 
23082007/Olympus Soft Imaging Solutions GmbH software. 
2.3.4. Structural characterization using Synchrotron SAXS  
The structural information of the produced CLs, such as the fraction of 
multilayer vesicles in relation to SUVs and the bilayer size, was obtained through 
Small Angle X-ray Scattering (SAXS) analysis. The SAXS experiments were 
performed on the beamline SAXS1 at the Brazilian Synchrotron Light National Lab 
(LNLS) using a beam energy of 8 keV (=1.55 Å) and a sample to detector 
distance of 561 mm. The measured intensity is displayed as a function of the 
reciprocal space momentum transfer modulus q=4 sin() / , where 2 is the 
scattering angle and  is the radiation wavelength. The typical range of q values 
was  0.017 Å-1 to 0.45 Å-1. 
The analyses were performed using the models described in our previous 
work [20]. We assumed that the system was composed of two phases: a fraction of 
unilamellar vesicles and a fraction of multilamellar vesicles. Therefore, the 
scattering intensity I(q) can be written as follows: 
 
)()()( qSqPqI eff                                        (Equation 1) 
where P(q) is the bilayer form factor. In addition, the effective structural factor 
Seff(q)=fsb+fmSMCT(q), where fsb is a constant related to the fraction of single 
bilayers, fm represents the relative fraction of multilayers, and SMCT(q) is the 
Modified Caillé structure factor.  
2.4. Process productivity 
To verify the feasibility of our microfluidic setup system for gene delivery and 
vaccine therapy applications, the molar productivity of the produced CL was 
calculated from Equation 2 as follows:   
 1
100.6 5


 
FRR
CQ
P
LipT
     (Equation 2) 
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where P is the molar productivity of the CL produced by the microfluidic devices in 
mmol/s, QT is the total volumetric flow in the outlet channel in µL/min, and Clip is 
the lipid concentration of the dispersion in ethanol in mM. 
2.5. Culture and transfection of mammalian cells  
We used the vector model pVAX-LUC as the plasmid DNA (pDNA) and 
luciferase as the reporter gene [21]. The pDNA was amplified in Escherichia 
coli bacteria and purified using the PureLink™ HiPure Plasmid DNA Purification 
Kit-Maxiprep K2100-07. The extruded CLs that were used as the control were 
prepared by the thin film method that was previously described [20]. The pDNA/CL 
complexes were prepared by adding the pDNA to the CLs at a molar charge ratio 
of 6, which balances the positive charges from the cationic lipid (DOTAP) and the 
negative charges from the pDNA phosphate group.  
The cytotoxicity and the ability to transfect human epithelial carcinoma 
(HeLa) cells in vitro of the complexes were tested using a previously described 
protocol [21]. The cells were maintained in an F-12 (Ham) nutrient mixture (Gibco, 
UK), which contained 10% (v/v) fetal bovine serum (FBS) (Gibco, UK) and was 
supplemented with non-essential amino acids (Gibco, UK), gentamicin (Gibco, 
UK), sodium pyruvate (Gibco, UK), and antibiotic–antimycotic (Gibco, UK). The 
cultures were incubated under standard conditions (37°C, 5% CO2 in a humid 
atmosphere), allowed to grow to near confluency and harvested with trypsin. After 
reaching confluence, the cells were seeded into 24-well culture plates (5104 cells 
per well), incubated for 48 h and transfected with 0.8 g of pVAX-Luc per well. The 
luciferase activity was determined using the Luciferase assay kit from Promega 
according to the manufacturer’s protocol. The relative light units (RLUs) were 
measured with a chemiluminometer (Lumat LB9507, EG&G Berthold, Germany) 
and the luciferase activity was expressed as RLU/mg protein. The total protein was 
measured using a BCA protein assay kit (Pierce).  
To simulate the ethanolic residual of the CLs produced by the microfluidic 
method, 10 % (v/v) ethanol was added to the extruded CLs obtained by the thin 
film method prior to measuring their in vitro citotoxicity. We used the cell 
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proliferation reagent WST-1 from Roche Molecular Biochemicals (Mannheim, 
Germany). The cells were seeded onto 96-well microplates (7,000 cells per well) in 
100 μL of culture medium and incubated for 48 h under the same conditions 
described above, at which point the pDNA/CLs complexes were added. At the end 
of the treatment, 10 μL of the cell proliferation reagent WST-1 was added to each 
well; the cells were then incubated for 2 h. The results of the WST-1 assay were 
then measured using a scanning multiwell spectrophotometer (ELISA-Reader 
MRX, Dynex Technologies) at wavelengths of 440 and 650 nm.  
2.6. Experimental design for response surface methodology 
The CL production conditions were examined by the Response Surface 
Methodology [22] to determine the particle size as a function of the microfluidic 
parameters FRR and Vf, and the system parameter Clip. A total of 17 experimental 
trials were carried out, which were designed on a Central Composite Rotatable 
Design (CCRD) with six axial and three central points. All the experiments were 
randomized. The statistical significance of the results of the experimental design 
data was determined using the STATISTICA 5.5 software (Statsoft Inc.).  
3. Results and Discussion 
The development of microfluidic devices for liposome production has been 
extensively explored by different researchers, and the potential of using these 
devices has already been proven. However, most of the processes used a lipid 
content (Clip) lower than 5 mM [13-15, 23, 24], which is the approximate solubility of 
lipids in ethanol and isopropanol. Thus, the liposomal formulations obtained were 
at concentrations of ~0.5 mM, which have limited use. In the field of gene therapy 
and vaccine, for example, a low lipid content in the liposomal formulation is 
inadequate. Systematic studies on the use of microfluidic systems for the 
production of cationic liposomes have yet not been presented in the scientific 
literature.  
We used the hydrodynamic focusing technique to find the operating 
conditions that would produce liposomes with the highest lipid concentration and 
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productivity. In addition to using a single hydrodynamic focusing (SHF) system 
(Figure 1A), we developed a double hydrodynamic focusing (DHF) system (Figure 
1B) to produce liposomes with two flow focusing regions, which increases the 
surface area involved in the organic-aqueous diffusion phenomenon. 
In both cases, the three lipids (EPC/DOTAP/DOPE 50:25:25% molar) were 
dispersed in ethanol at specified lipid contents (Clip) prior to processing. A previous 
Langmuir Monolayer study on these lipids demonstrated that a uniform dispersion 
of the lipids in ethanol can be attained because there are attractive forces that 
maintain the lipids balanced at their molar proportion [25]. In addition, we designed 
experiments (CCRD - 23) to evaluate the influence of FRR, Vf and Clip on the 
resultant particle size and polydispersity.  
3.1 Cationic liposome production using the single hydrodynamic focusing 
(SHF) microfluidic device 
We studied the SHF device using the CCRD experimental matrix.  The 
resulting particle size and polydispersity index are shown in Table 1 for each 
experimental condition tested. As shown in Table 1, we obtain cationic liposomes 
with lipid concentrations ranging from ~ 0.6 to 7 mM by varying the Clip from 9 to 92 
mM, the surface velocity from 0.08 to 0.16 and the FRR from 8 to 18. 
The highest lipid concentrations of the liposomal formulations (~7 mM) were 
obtained in the third and fourth runs (high Clip and low FRR), whereas the lowest 
concentration (~0.6 mM) was produced in the eleventh run (low Clip and high FRR) 
(Table 1). 
The differences between the different runs were analyzed by determining 
the variance using ANOVA to determine the statistical significance of the 
differences, as summarized in Table 2. The analysis of the F-test results reveals 
that the model of the SHF device is only predictive for the particle size because the 
calculated F-value (2.745) was slightly higher than the listed F (2.72), and the 
obtained R-squared (0.78) was considered satisfactory. Therefore, all the factors 
(Clip, Vf and FRR) significantly influenced the resulting particle size with a 
confidence level of 90%. The polydispersity response, however, did not show any 
significant variation. 
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Table 1. CCRD matrix with the real and coded values (in parenthesis) for the 
factors (Average Flow Velocity (Vf), Lipid Concentration dispersed in ethanol (Clip), 
and Flow Rate Ratio (FRR)) tested and the responses (Particle Size and 
Polydispersity (Pdl)) obtained using the SHF device in the production of cationic 
liposomes.  
 Factors  Responses 
Run Vf (mm/s) Clip (mM) FRR 
 
PdI ± SD 
Particle Size(i) 
(nm ± SD) 
1 95 (-1) 25 (-1) 10 (-1)  0.34 99.3 
2 143 (+1) 25 (-1) 10 (-1)  0.31 85.8 
3 95 (-1) 75 (+1) 10 (-1)  0.28 233.9 
4 143 (+1) 75 (+1) 10 (-1)  0.20 145.2 
5 95 (-1) 25 (-1) 16 (+1)  0.27 264.2 
6 143 (+1) 25 (-1) 16 (+1)  0.21 172.2 
7 95 (-1) 75 (+1) 16 (+1)  0.23 173.1 
8 143 (+1) 75 (+1) 16 (+1)  0.29 241.0 
9 80 (-1.68) 50 (0) 13 (0)  0.29 240.5 
10 160 (+1.68) 50 (0) 13 (0)  0.32 198.7 
11 120 (0) 8 (-1.68) 13 (0)  0.25 88.0 
12 120 (0) 92 (+1.68) 13 (0)  0.25 202.4 
13 120 (0) 50 (0) 8 (-1.68)  0.24 130.7 
14 120 (0) 50 (0) 18 (+1.68)  0.50 508.6 
15 120 (0) 50 (0) 13 (0)  0.31 254.6 
16 120 (0) 50 (0) 13 (0)  0.33 260.9 
17 120 (0) 50 (0) 13 (0)  0.32 257.9 
 (i)The average hydrodynamic diameter was weighed by the intensity. 
Table 2. ANOVA for the Cationic Liposomes produced by the Single Hydrodynamic 
Focusing (SHF) device.  
Source of 
Variation 
Sum of squares Degrees of freedom Mean square F-test 
PdI 
Particle 
size 
PdI 
Particle 
Size 
PdI 
Particle 
Size 
PdI 
Particle 
Size 
Regression 0.03 122,706.7 9 9 0.004 13,634.1 0.654 2.75 
Residual 0.04 34,723.5 7 7 0.006 4,960.5   
Total 0.07 157,430.2 16 16     
PdI: F9;7;0.1= 2.72;  R
2 = 0.457 
Particle size: F9;7;0.1= 2.72; R
2 = 0.779 
Based on the statistical analysis, we plotted the response surfaces (Figure 
2) to verify the change in particle size behavior under the range of conditions 
studied; to visualize these surfaces, the independent variables were analyzed in 
pairs. The response surfaces for the particle size as a function of Vf and Clip, 
(Figure 2A) and as a function of Vf and FRR (Figure 2B) show that the range of Vf 
values studied does not strongly influence the particle size. Jahn and co-workers 
[13-15] found a similar effect on liposomes assembled in similar microchannels at 
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lower Clip values (5 mM). Huang and co-workers [24] reported a slight change in 
the particle size obtained with different Vf values. The low influence of this variable 
on the particle size has also been observed in the synthesis of niosomes using the 
SHF technique [26]. This low influence of Vf on the particle size might indicate that 
the microfluidic system can operate at higher total volumetric flow rates, which 
could increase the productivity. 
     
 
Figure 2. Response surfaces of the particle size of cationic liposomes produced by the 
single hydrodynamic focusing (SHF) microfluidic device as a function of the Lipid 
Concentration of the dispersion in ethanol (Clip), the Average Flow Velocity (Vf) and the 
Flow Rate Ratio (FRR). 
Additionally, the Vf is inversely proportional to the fluid residence time in the 
microreactor. Thus, in the explored ranges, the residence time was sufficient. At 
the axial minimum (Vf = 80 mm/s) and maximum (Vf = 160 mm/s) points, the 
residence times are 0.38 and 0.19 s, respectively.  
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The Clip is another important parameter that contributes to the increase in 
the production of CL in microfluidic devices because an increase in this 
concentration directly results in an increase in the lipid concentration of the final 
liposomal formulation. The influence of this independent variable is illustrated in 
Figures 2A and C. As shown, the system produces smaller particles for lower 
values of Clip. A similar behavior was reported by Pradhan and co-workers [27], 
who studied the effect of lipid flow concentration on liposome particle behavior. 
However, the authors used lower lipid concentrations in the organic phase and 
obtained a maximum lipid concentration in the liposomal solution of ~2 mM.  
 This influence of Clip on particle size was expected based on the liposome 
formation theory [28]. For different liposome production methods that involve the 
diffusion of an organic solvent (e.g., ethanol injection method), phospholipid 
bilayers fragments (PBFs), which are highly unstable and take the formation of 
vesicles, form during the diffusion process. However, in the formation of liposomes 
using microfluidic devices, the aggregation process is controlled by the ordered 
ethanol and water mixing process. The lower polarity regions of the solvent make 
the lipids increasingly less soluble, which encourages them to self-assemble into 
PBFs. To minimize the hydrophobicity of the PBF edges, these PBFs form 
spherical vesicles with an aqueous interior core [23], as shown in the schematic in 
Figure 3.  
 This process occurs simultaneously with the ethanol/water diffusion. In fact, 
the formation of the PBFs might be an additional mass transfer resistance for the 
diffusion of the ethanol. If the ethanol/water diffusion is completed before all the 
lipid particles have formed vesicles (or at least PBFs), the remaining lipids will most 
likely aggregate in an uncontrolled manner, leading to the formation of liposomes 
with uncontrolled sizes. This happens, for example, when the proportion of ethanol 
to lipid is not adequate, such as at a high lipid content. Therefore, in the production 
of CLs in microfluidic devices using hydrodynamic focusing, the ethanol/lipid mass 
rate (Clip) that results in the maximal lipid concentration must be determined. 
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Figure 3. Schematic diagram of the hypothesized mechanism for liposome formation in a 
microfluidic hydrodynamic focusing device. The central stream is composed of the lipid 
dispersion in ethanol, which is hydrodynamic compressed by the two adjacent aqueous 
streams. The mixing of the water and ethanol through the main channel forms 
phospholipid bilayer fragments (PBF) that grow into vesicles to stabilize their hydrophobic 
PBF edges. The decrease in ethanol concentration destabilizes the PBFs, influencing then 
to close into vesicles and thus form liposomes. 
This hypothesis was confirmed when we compared our results from Table 1 
with a previous study that used a microfluidic device with a higher Clip [29]. At the 
same lipid composition, using ethanol as the organic solvent, and with FRR values 
ranging from approximately 7 to 11 and Vf values ranging from 1.02 to 1.35 mm/s, 
a Clip of 100 mM results in the formation of cationic liposomes with PdI values of 
0.44 to 0.62, which indicate that these particles were formed in an uncontrolled 
manner. 
We can also observe that an increase in FRR also results in an increase in 
the particle size. However, our experimental data are not in agreement with Zook 
et al. [23] and Jahn et al. [14, 15]. These studies reported an increase in liposome 
size with a decrease in FRR using comparable systems, a similar FRR range and a 
lower Clip. However, because these authors used isopropanol as the organic 
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solvent instead of ethanol, the differences in the influence of FRR could be a 
consequence of the molecular diffusivities of the different organic solvents into 
water. We decided to use ethanol because it is an acceptable solvent for in vitro 
experiments with human applications [30]. The molecular diffusivities (DAB) for 
isopropanol and ethanol in water at 25° C are 0.87 x 10-9 and 1.132 x 10-9 m2/s, 
respectively [31]. Therefore, the ethanol DAB is 51.7% higher than the isopropanol 
DAB. This difference will result in differences in the mass transfer rate and thus in 
the process of liposome formation.  For a constant Vf and Clip, an increase in the 
FRR means that the proportion of water to solvent in the microchannel increases. 
This decrease in the amount of ethanol means that the diffusion process will be 
faster and thus require a shorter distance, which compromises the balance 
between the ethanol diffusion and the PBF formation, causing a larger liposome to 
be produced. However, considering the lower molecular diffusivity of isopropanol, a 
decrease in the amount of isopropanol will contribute positively to the balance 
between the organic solvent mass transfer and the PBF formation, which results in 
better control of the liposome size.  
3.2 Cationic liposome production using the double hydrodynamic focusing 
(DHF) microfluidic device 
The liposomes produced by the DHF device were explored using the same 
variable ranges that were used in the investigation of the SHF device. The matrix 
of experimental conditions (CCRD (23)) and the corresponding responses (particle 
size and polydispersity) obtained using the DHF device are shown in Table 3. The 
analysis of variance (ANOVA) of the model in the responses is shown in Table 4. 
As shown in Table 4, the surface model is not predictive because the F-
values for the polydispersity index and particle size are 0.781 and 0.745, 
respectively, which are lower than the listed F-value (2.72 for both cases, with α = 
0.10).  In addition, the R-squared values are 0.501 and 0.489 for the polydispersity 
index and particle size, respectively. These results suggest that the operational 
range for the DHF is different from the SHF. 
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Table 3. CCRD matrix with the real and coded values (in parenthesis) for the 
factors (Average Flow Velocity (Vf), Lipid Concentration of the dispersion in ethanol 
(Clip) and Flow Rate Ratio (FRR)) tested and the responses (Particle Size and 
Polydispersity (Pdl)) obtained using the DHF device in the production of cationic 
liposomes.  
 Factors  Responses 
Run Vf (mm/s) Clip (mM) FRR 
 
PdI ± SD 
Particle Size 
(nm ± SD) 
1 95 (-1) 25 (-1) 10 (-1)  0.30 298.2 
2 143 (+1) 25 (-1) 10 (-1)  0.31 243.1 
3 95 (-1) 75 (+1) 10 (-1)  0.36 384.2 
4 143 (+1) 75 (+1) 10 (-1)  0.32 312 
5 95 (-1) 25 (-1) 16 (+1)  0.31 285.6 
6 143 (+1) 25 (-1) 16 (+1)  0.30 245.7 
7 95 (-1) 75 (+1) 16 (+1)  0.64 659.2 
8 143 (+1) 75 (+1) 16 (+1)  0.29 266.4 
9 80 (-1.68) 50 (0) 13 (0)  0.31 243.8 
10 160 (+1.68) 50 (0) 13 (0)  0.52 593.7 
11 120 (0) 8 (-1.68) 13 (0)  0.28 262.9 
12 120 (0) 92 (+1.68) 13 (0)  0.25 202.4 
13 120 (0) 50 (0) 8 (-1.68)  0.87 1096 
14 120 (0) 50 (0) 18 (+1.68)  0.36 353.3 
15 120 (0) 50 (0) 13 (0)  0.57 612.3 
16 120 (0) 50 (0) 13 (0)  0.35 344.9 
17 120 (0) 50 (0) 13 (0)  0.49 530.1 
 
 
Table 4. ANOVA for the Cationic Liposomes produced by the Double 
Hydrodynamic Focusing (DHF) device.  
Source of 
Variation 
Sum of squares 
Degrees of 
freedom 
Mean square F-test 
PdI 
Particle 
size 
PdI 
Particle 
Size 
PdI 
Particle 
Size 
PdI 
Particle 
Size 
Regression 0.22 408670.9 9 9 0.024 45407.9 0.781 0.745 
Residual 0.21 426570.4 7 7 0.031 60938.6   
Total 0.43 835241.4 16 16     
PdI: F9;7;0,1= 2.72;  R
2 = 0.501 
Particle size: F9;7;0,1= 2.72; R
2 = 0,489 
The particle sizes obtained for the liposomes by the DHF microfluidic device 
ranged between 202.4 and 1096 nm and the PdI values ranged from 0.25 to 0.87. 
A comparison of these particles to those produced using the SHF microfluidic 
device, which exhibited ranges of particle sizes and polydispersity indexes 
between 85.8 and 508.6 nm and between 0.20 and 0.50, respectively, reveals that 
the particles seem to be produced in an uncontrolled manner in the DHF. 
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3.3. Comparison of the effect of flow velocities on the particle size of the 
liposomes produced using the SHF and DHF microfluidic devices 
The analysis of the experimental results shown in Tables 3 and 4 shows that 
the variable ranges studied in the production of liposomes using the DHF device 
were not optimized. Thus, it is probable that, as the interfacial area is increased, 
the DHF configuration allows the system to work at higher total volumetric flow 
rates, which would result in higher productivity. To confirm this hypothesis, we kept 
the FRR and Clip constant at 10 and 25 mM, respectively, and performed a 
comparative analysis on the particle size obtained using both devices over different 
ranges of Vf; the results of this study are presented in Figure 4.  
 
Figure 4. Effect of average flow velocity (Vf) on particle size (intensity-weighted) for the 
production of cationic liposomes using the Single (SHF) and Double (DHF) Hydrodynamic 
Focusing devices. Production conditions: FRR of 10 and Clip of 25 mM. The error bars 
represent the standard deviation of three independent experiments. 
Figure 4 shows the effect on particle size of a large range of Vf values in the 
production of CLs using both devices. The CLs produced using the SHF device at 
higher flow rates exhibited larger particle sizes, which is contradictory with the 
previous experimental results for SHF (Table 1 and Figure 2) that identified the Vf 
does not strongly influence the particle size. However, the previous studies used a 
Vf range from 80 to 160 mm/s, whereas Figure 4 illustrates the influence of higher 
values of Vf and indicates that Vf values higher than 160 mm/s the SHF device 
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produce liposomes with increased size, from approximately 100 to 180 nm. It is 
possible that, for values of Vf higher than 160 mm/s, the convective contribution 
due to the increase in flow velocity disturbs the ethanol and water mixing, which 
modifies the lipid self-assembly into PBFs and thus produces liposomes of larger 
size.  
The behavior observed with the DHF device was the opposite of that 
observed with the SHF. The DHF was able to produce CLs with an approximated 
size of 100 nm at Vf values higher than 160 mm/s (Figure 4), which implies a 
higher productivity level than that achieved with the SHF. It is possible that 
doubling the interfacial area in the DHF resulted in a decrease in the distance 
required to complete the ethanol diffusion leading to a compromised balance 
between the ethanol diffusion and the lipid formation. When Vf is increased to 
values higher than 160 mm/s, the residence time decreases and the distance 
required to complete the ethanol mass transfer increases. Consequently, it is 
possible that a longer microchannel distance in the microfluidic device will ensure 
controlled BPF and liposome formation. 
The productivity of the DHF device is higher than the SHF device because it 
was possible to use higher fluid flow velocity, or total volumetric flow rate; these 
results are discussed in detail in Table 5.  
3.4. Flow properties and mixing time 
We calculated two dimensionless numbers to characterize and classify the 
flow properties of our system, which make it possible to compare it to other 
systems with different dimensions. Dimensionless numbers are widely used in 
various branches of chemical engineering because of their clear physical 
interpretation, which contributes to the physical comprehension of the phenomenon 
involved in the process under study [32]. The Reynolds number (Re) represents 
the ratio of the inertial forces to the viscous forces. It is generally considered to be 
the most important dimensionless parameter in studies of transport phenomena in 
fluid flows and is expressed as follows [33]: 
       (Equation 3) 
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where Dh is the hydraulic diameter,  is the fluid density and  is the dynamic 
viscosity. The second dimensionless parameter that we used is the Peclet number 
(Pe), which correlates the transport via hydrodynamic convection (flow of the 
medium, Vf) and the molecular diffusion of mass (mass diffusivity DAB) [32]. Pe 
therefore represents the ratio of convection and diffusion mass transports and is 
given by the following equation: 
        (Equation 4) 
where L is the microchannel length. The Re and Pe values for our system ranged 
from 11.1 to 33.2 and from 2.52106 to 7.57106, respectively. These results are 
similar to those reported by other studies on liposome synthesis in microchannels. 
Zook and co-workers [23] worked at a similar Re value of 22.9 and a slightly higher 
Pe number of 7.66106 due to their longer channel length. Jahn and co-workers 
[15] operated at lower Re numbers ranging from 2 to 8 and at lower Pe values of 
0.25106 to 0.96106. As expected in microfluidic systems, the Re numbers under 
all operation conditions were much lower than 1,800, which is the onset of the 
transition of laminar to turbulent [34]. All the Pe values obtained indicate the 
predominance of advection over diffusion in the systems studied. 
The mixing time is also an important parameter in microfluidic processes 
because it dictates whether the fluids will attain complete mixing through the length 
of the microchannel. The estimation of the time required for the complete diffusion 
of ethanol into the aqueous stream is based on the mass continuity equation [33, 
35]. Considering that the mass transfer process occurs in laminar flow, without a 
chemical reaction and in two directions, the mean molar flux of ethanol (NA), or the 
molar diffusion rate along the microchannel, is given by the following equation:  
     (Equation 5) 
where v is the velocity of the aqueous phase, which is calculated by the volumetric 
rate of water per the flow area of water, L is the microchannel length, CA0 
corresponds to the concentration of ethanol at the ethanol stream and CA is the 
concentration of ethanol at the channel wall, which is considered to be zero at the 
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beginning of the process. According to the conditions shown in Figure 1, the 
corresponding values of v for the SHF and DHF devices are 0.033 and 0.095 m/s, 
respectively. Therefore, because CA0 is the concentration of pure ethanol, which is 
17.13 kmol/m3, the values of NA for the SHF and DHF devices are 7.010
-4 and 
11.810-4 kmol/m2 s, respectively. Thus, the mixing time required for the two fluids 
to be completely diffused can be calculated by Equation 6 as follows: 
        (Equation 6) 
where n is the total moles of ethanol diffused per square meter in both diffusion 
directions and is given by the following equation: 
       (Equation 7) 
where  is the thickness of the lipid phase in the direction of diffusion,  represents 
the density of ethanol and M is the molecular weight of ethanol. Therefore, the 
mixing times, , required for the SHF and DHF devices are 3.34 and 1.29 ms, 
respectively. This  can be interpreted as the minimum residence time required to 
complete the liposome formation. These values are 100-fold lower than the 
residence time that was previously estimated, which ranged from 315 ms (95 
mm/s) to 111 ms (286 mm/s), and thus justify the weak influence of the range of Vf 
values studied in the CCRD experiments on the size of the liposomes produced 
using both the SHF and DHF devices. At Vf values that are higher than 160 mm/s, 
however, the particle size is influenced by the Vf, as observed in Figure 3. In 
addition to the difference between the water-ethanol diffusion time and the 
residence time, the particle size variations are most likely due to the combined 
effects of the diffusion and convection phenomena reflected by the Pe numbers of 
both geometries, which are above 5.05  106 for Vf values above 160 mm/s.  
The proper formation of liposomes is dependent on the balance between the 
ethanol mass transfer and the PBF formation. This process occurs in a controlled 
manner until the ethanol and water streams are completely mixed. Therefore, the 
low mixing times indicate that the mixing process is completed close to the 
beginning of the microchannel, which results an uncontrolled formation of PBFs. 
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Consequently, to produce liposomes in a controlled manner, the maximum Clip in 
the alcoholic stream will need to be limited.  
3.4. Analysis of the Productivity and Physicochemical and Structural 
characterization of the Cationic Liposomes Produced by the SHF and DHF 
Devices 
For each microfluidic device, the best condition that produced CLs with a 
particle size less than 150 nm was chosen; the respective molar productivities for 
these conditions were then estimated, as summarized in Table 5. The selected 
conditions for the SHF and DHF devices involved Vf values of 165 mm/s and 285 
mm/s at a FRR of 10 and a Clip of 25 mM. As shown, we obtained higher molar 
productivities (approximately 13-fold higher) compared to previous reports on 
liposome production in microfluidic systems, in which the maximum values were 
approximately 0.5 mmol/s [13] and 2.5 mmol/s [15]. Although the particle size and 
polydispersity index of the CL produced by both devices are significantly different, 
the values obtained are considered suitable for gene delivery and vaccine therapy. 
Table 5. Physicochemical properties of cationic liposomes produced by the single 
and double hydrodynamic focusing microfluidic devices (SHF and DHF, 
respectively). Operating parameters: FRR of 10, Clip of 25 mM and Vf of 165 and 
285 mm/s for the SHF and DHF, respectively. 
 Hydrodynamic Microfluidic Devices 
 SHF DHF 
Particle Size(i) (nm) 124.9 ± 8.9 101.9 ± 1.6* 
Polydispersity Index 0.31 ± 0.05 0.34 ± 0.02 
Zeta Potential (mV) +57.4 ± 3.6 +65.0 ± 2.6* 
Molar productivity (mmol/s) 19.1 ± 2.8(ii) 32.7 ± 4.6(ii)* 
Results represent mean ± SD of three independent experiments 
(i) Intensity-weighted averaged hydrodynamic diameter. 
(ii) Standard deviation based on the Propagation Uncertainties Theory  
(Taylor, 1997) 
* Significantly different (p<0.05) when compared to the SHF. 
The liposomes produced by both the SHF and DHF devices exhibited a 
positive zeta potential in water of 57.4 and 65 mV, respectively, which indicates 
that the liposomes are cationic and thus suitable for in vitro transfection 
experiments. The difference in the zeta potentials is most likely due to the 
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modifications in the physicochemical properties that occur when shear stress is 
applied during the liposome formation [36-38]. The difference in the flow velocity 
between the microfluidic devices generates differences in the shear rates that are 
applied in the liposome formation region, which is then reflected on the zeta 
potential of the vesicles that are produced. 
The particle size distributions of the CLs produced by both the SHF and 
DHF microfluidic devices at Clip values of 25 mM for both, FRR values of 10 for 
both and Vf values of 120 and 240 of mm/s, respectively, are summarized in 
Figures 5A and 6A. The particle size of the CLs produced using the SHF device 
range from 60 to 400 nm, whereas the particle size distribution of the CLs 
produced by the DHF device show two populations, a major one that ranges in 
particle size from 20 to 400 nm and a second (smaller) population approximately 
4,000 nm in size. 
The morphology of the CLs produced by both the SHF and the DHF 
microfluidic devices were evaluated by transmission electron microscopy (TEM) 
using a negative staining technique (Figures 5B and 6B). As shown, the CLs 
obtained have rather spherical shapes with diameters in the order of 100 nm. The 
isolated vesicles can be observed without any evidence of aggregation and/or 
fusion. It is also possible to observe the presence of a well-defined region 
surrounding the particle, which is illustrated by the arrowheads in Figures 5B and 
6B. The presence of this region suggests that the CLs produced by both devices 
are unilamellar with an estimated lamellar thickness of ~6 nm. This estimate is in 
agreement with Trevisan and co-workers [29], who applied small angle X-ray 
scattering techniques to determine a bilayer thickness of 5.9 nm in CLs with the 
same lipid composition produced by different methods. 
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Figure 5. (A) Particle size distributions (intensity weighted) obtained by DLS and (B) 
Transmission electron micrographs of cationic liposomes produced by the Single 
Hydrodynamic Focusing microfluidic device at a Clip of 25 mM, FRR of 10 and Vf of 143 
mm/s. The bars represent 100 nm. 
 
    
Figure 6. (A) Particle size distributions (intensity weighted) obtained by DLS and (B) 
Transmission electron micrographs of cationic liposomes produced by the Double 
Hydrodynamic Focusing microfluidic device at a Clip of 25 mM, FRR of 10 and Vf of 285 
mm/s. The bars represent 100 nm. 
To confirm the unilamellar nature of the cationic liposomes produced by the 
SHF and DHF microfluidic devices, we performed SAXS experiments at a Clip of 75 
mM, FRR of 10 and Vf of 143 mm/s.  Figure 7 shows the scattering intensity for two 
representative CLs produced by the SHF and DHF microfluidic devices. The fitting 
model that was used considered the presence of unilamellar and multilamellar 
vesicles [20]. The fraction of multilayers produced by both devices was 
approximately 4% and lower than 0.2% for the SHF and DHF devices, respectively; 
both of these values can be considered negligible. We therefore found that both 
A 
A 
B 
B 
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methods produce unilamellar cationic liposomes, which confirms the previous 
finding from the TEM analysis. This is the first report that characterizes the 
liposomes produced in microfluidic devices as unilamellar through SAXS. 
 
Figure 7. Small Angle X-ray Scattering intensity of cationic liposomes produced by the 
Single (SHF) and Double (DHF) Hydrodynamic Focusing devices with respective fitting 
curves. Production conditions: Clip of 75 mM, FRR of 10 and Vf of 143 mm/s. 
3.5. Biological evaluation of the Cationic Liposomes Produced by the SHF 
and DHF Devices 
The cationic liposomes produced by the microfluidic methods contained 
residual organic solvent due to the lipid dispersion; therefore, we evaluated the 
effect of ethanol on the proliferation of HeLa cells by determining the percent of cell 
survival 24 h post treatment using the WST-1 assay. We added ~10% (v/v) of 
ethanol to liposomes that were prepared through the traditional bulk method; this 
addition of ethanol would better simulate the liposomal formulations obtained by 
the microfluidic methods at a FRR of 10. As shown in Figure 8 (inset graph), no 
cytotoxic effects were observed in any of the test samples, which indicates that the 
presence of ~10% of ethanol in the culture medium did not influence cell viability. 
Therefore, it is feasible to use the CLs produced by microfluidic devices in in vitro 
studies without any additional dialysis processing steps. 
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Figure 8. In vitro efficacy on the transfection of HeLa cells with DNA 
complexed with cationic liposomes produced by the SHF and DHF microfluidic 
devices and the typical bulk process. Activity was expressed in RLU/mg protein. 
Free pDNA and Lipofectamine were used as negative and positive controls, 
respectively. Inset: Cell viability assay of cationic liposomes produced by the bulk 
process complexed with pDNA in the presence of ~10% (v/v) residual ethanol. 
Cells without treatment were used as the control. The data represent the means ± 
SD of six and three experiments in the inset and the main graph, respectively. * p < 
0.05 was considered statistically significant. 
The biological efficacies of the cationic liposomes produced by both 
microfluidic devices were examined in vitro in human epithelial carcinoma cells 
(HeLa) cells. The CLs were complexed with the plasmid DNA vector model pVAX-
Luc, as described by Toledo et al. [21]. The transfection was quantified by 
determining the luciferase activity after an incubation time of 24 h. The results, 
which are summarized in Figure 8, show the viability in transfected HeLa cells of 
the CLs produced by both microfluidic devices studied and the liposomes produced 
by the conventional bulk method. As shown in Figure 8, there is no (or very low) 
transfection with the use of naked DNA. The positive control (Lipofectamine®, a 
commercial transfection reagent) exhibited higher transfection levels than those 
achieved by the transfection of the CLs produced by either of the microfluidic 
devices. However, even though it results in a higher amount of transfection, 
lipofectamine is more cytotoxic than our lipid composition [20], which may render it 
unsuitable for any in vivo applications.  
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4. Conclusions 
In conclusion, we have demonstrated the potential of using microfluidic 
devices for the production of cationic liposomes at high yields; this was achieved 
with both single and double hydrodynamic focusing techniques. Both devices 
studied produced unilamellar CLs with average diameters of 100 to 130 nm and 
suitable characteristics for gene delivery and vaccine therapy at higher molar 
productivity than previous studies. The technology employed is particularly useful 
for CL production because of the advantages of using a continuous process, the 
reduced number of steps that are required, and the process intensification that is 
achieved.  
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Abstract 
 Aiming to evaluate the process parameters of the plasmid DNA/ cationic 
liposomes (pDNA/CL) complexes production in microfluidic systems, we studied 
two microfluidic devices: one with a simple straight hydrodynamic flow focusing 
(SMD) and a second one with barriers in the mixing microchannel (patterned walls, 
PMD). The conventional bulk mixing method was used as comparison. We 
complexed CL composed of egg phosphatidylcholine, 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine and 1,2-dioleoyl-3-trimethylammonium-propane (50/25/25% 
molar) and the pDNA vector model with luciferase as reporter gene at the molar 
ratio between positive and negative charge of 6, identified before in the best range 
for in vitro transfection in Hela cells. The results showed that the incorporation of 
the DNA into the liposomal structures was different for both microfluidic devices; 
the temperature influenced the average size of complexes produced by the simple 
microfluidic device, while it did not influence in the patterned walls. The differences 
were also observed in DNA probe accessibility into the complexes. The SMD 
yielded similar quantity of non-electrostatic bound DNA to that of the bulk mixing 
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method. Interestingly, the complexes produced by the PMD presented DNA probe 
accessibility decreased in 40% and achieved lower in vitro transfection levels in 
HeLa cells than the bulk mixing and simple microfluidic complexation methods. 
These differences are probably consequence on different association between 
DNA and CL controlled by the microfluidic devices. This study contributes to the 
development of rational strategies in controlling the formation of pDNA/CL 
complexes for further applications in gene and vaccine therapy. 
1. Introduction 
 Microfluidics is a multidisciplinary science and technology that process small 
amounts of fluids (10-9 to 10-18 liters) and is essentially dedicated to miniaturized 
plumbing and fluidic manipulation [1, 2]. Besides the small dimensions, 
microfluidics explores hydrodynamic characteristics to control in space and time 
concentrations of different molecules [3-7]. Unique transport properties are 
observed when employing microfluidic systems, that result in laminar flows and 
vastly increased surface-to-volume ratios [8]. 
 Unlike on the macroscale, where the mixing is generally made through 
turbulent flows, within microfluidic devices, the mixing occurs by molecular diffusion 
as influenced by convection, which is an inherently slow process. However, fast 
mixing time (in order of ms) in microfluidic devices can be achieved due to their 
small dimensions and thus a short diffusion length between the components [9, 
10]. In this fashion, a large number of micromixers with clever geometries have 
been designed to enhance the mixing efficiency by increasing the contact area 
between the mixing species as they flow along the mixing channel [11-14]. One 
prospective application of microfluidic processes is in the field of gene and vaccine 
delivery [15]. 
 Gene delivery is a potential method for treating of different diseases, 
including gene-related disorders, infectious diseases, AIDS, cancer etc [16]. It is 
based on the process of introducing into the cell nucleus an engineered DNA that 
encodes a functional, therapeutic gene to modulate cellular functions and 
responses [15, 17]. However, the efficient delivery needs DNA protection and the 
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DNA/Cationic liposome (CL) complexes are a promising strategy for nonviral gene 
therapy [18]. Liposomes are vesicles of colloidal dimensions formed when 
phospholipids self-assembly in aqueous media with an interior core, mimicking cell 
membranes. The use of cationic lipids allows the electrostatic complexation with 
DNA. Cationic liposomes (CL) effectively protect the DNA from extracellular matrix 
and shuttles it inside the cell [15, 18]. 
 The production of liposomes using microfluidic hydrodynamic focusing 
devices has been extensively studied [19-23]. Recently, our research group 
investigated the production of cationic liposomes in microfluidic devices using a 
lipid composition previously studied for tuberculosis gene vaccination and 
treatment [24-27]. However, the final application for gene vaccine or therapy 
requires the electrostatic complexation with the therapeutic molecule, the plasmid 
DNA. The spontaneous complexation process between DNA and CL relies on 
DNA/CL packing. Depending on the lipid composition, molar charge ratio between 
positive (from cationic lipids) and negative charges (from the DNA phosphate 
group) (R+/-), temperature of complexation, concentration of the solutions, lipid and 
DNA mixture ratio and order of mixing of the solutions, complexes with different 
morphological and physicochemical characteristics can be obtained [18, 28-30]. 
These differences generate different biological results [31]. Currently, the 
conventional method of preparing nonviral complexes is the bulk mixing (BM) 
process in which the two solutions are mixed followed by hand shaking or brief 
vortexing [30, 32, 33]. Due to these several factors that influence on DNA/CL 
complexes formation, the conventional BM method for preparation of DNA/CL 
complexes may yield inconsistent and poor reproducible transfection efficiencies 
[33, 34], probably due to uncontrolled complexation process. Consequently, the 
development of different strategies that can produce DNA/CL complexes with 
narrow particle size distribution and polydispersity is essential for the reproducibility 
of gene transfection results, attending the requirements for applications in gene 
and vaccine therapy. 
 Another important fact is the future demand for higher quantities of DNA/CL 
complexes for clinical trials and considering the difficulties in controlling the 
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complexation between DNA and LC using bulk methods at higher volumes, 
microfluidics emerges as a promising strategy that can be explored to increase the 
productivity and the for the development of innovative processes. 
 The use of microfluidic devices for forming nonviral carriers and DNA 
complexes has been previously demonstrated, such as employing the 
hydrodynamic flow focusing technique with the central DNA stream being focused 
for the two adjacent streams with the nonviral carriers [35-38], as well as 
employing picolitre incubators, in which the lipid and DNA solutions are confined 
into droplets formed by emulsion water in oil with a centrifugation post-processing 
step for separating the organic solvent [34, 39]. However, as far as we know, there 
has been no systematic study on the production of DNA/CL complexes in 
microfluidic flow focusing devices exploring operational parameters. 
 In this research, we investigated the parameters involved in the continuous 
production of DNA/CL complexes employing two microfluidic devices, one with a 
simple hydrodynamic flow focusing microfluidic device (SMD) (Figure 1A) and a 
second one with barriers in mixing channel (patterned microfluidic device, PMD, 
Figure 1B) with contraction and expansion regions, using the complexes produced 
by the BM method as control, aiming at the development of processes for the 
formation of DNA/CL complexes in microfluidic devices, which is a continuous flow 
process, is able to achieve the process intensification by producing such 
complexes with desired physicochemical properties.  
2. Materials and Methods 
2.1. Materials 
 Lipid were Egg phosphatidylcholine (EPC), 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) and 1,2-dioleoyl-3-trimethylammonium-propane 
(DOTAP) (50/25/25% molar) from Lipoid and used with no purification. Absolute 
ethanol was purchase from Sigma.   
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2.2. Microfluidic Devices Fabrication 
 The polydimethylsiloxane (PDMS)/glass microfluidic devices fabrication was 
carried out according to Moreira et al. [40] employing conventional UV 
photolithographic and soft-lithography methods. The design of the devices 
geometries were projected using AutoCAD (Autodesk). Basically, the mask layouts 
were photo-plotted with 8000 dpi resolution and the UV exposures made in a MJB-
3 UV300 contact mask aligner (Karl-Suss, Garching, Germany). Sylgard 184 
Silicone Elastomer Kit (Dow Corning, Midland, MI, USA) was used as material 
precursor of PDMS layers with a weight ratio of 1:10 of sylgard curing agent and 
prepolymer base, respectively. PDMS channels and glass were irreversible sealed 
by oxidizing PDMS surfaces and cleaning glass substrates which were placed for 
20 s exposition in an oxygen plasma cleaner (Plasma Technology PLAB SE80 
plasma cleaner, Wrington, England). Immediately after removal from plasma, the 
two pieces were put into contact, manually aligned and allowed to stand for two 
hours. All channels had a rectangular cross section with a depth of 100 m and a 
width of 140 m, as depicted in Figure 1.  
 The microfluidic hydrodynamic focusing geometry of the Figure 1A, named 
here as simple microfluidic device (SMD), has a single straight channel of 30 mm 
long. The second geometry, Figure 1B, has patterned walls with uniform barriers, 
or blocks, throughout the channel and is 130 mm long channel (PMD). The barriers 
are used to form swirling sections, accelerating the mixing time.  
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Figure 1. Schematic diagram of (A) simple microfluidic hydrodynamic focusing device with 
inset illustrating the hydrodynamic focusing (SMD). (B) Patterned microfluidic device and 
the inset illustrating the geometry and dimensions of the barriers (PMD). The 
microchannels are 140 µm wide and 100 µm deep. 
2.3. Plasmid DNA purification 
 We used pVAX-Luc as plasmid DNA vector model with luciferase as 
reporter gene and the human cytomegalovirus (CMV) immediate-early promoter 
[41]. The plasmid DNA was amplified in Escherichia coli bacteria and purified using 
PureLink™ HiPure Plasmid DNA Purification Kit-Maxiprep K2100-07 (Invitrogen). 
The DNA quality and quantity were spectrophotometrically measured with an ND-
1000 NanoDrop UV-Vis spectrophotometer (PeqLab, Erlangen, Germany).  
2.4. Cationic Liposome Production 
 The CL production was carried out in a hydrodynamic flow focusing 
microfluidic device (Figure 1A), according to Balbino et al [42]. Briefly, the lipids 
EPC, DOTAP and DOPE (50:25:25% molar) dispersed in ethanol at a lipid 
concentration of 25 mM and deionized water were loaded into an 1mL and into two 
3mL glass syringes, respectively, at room temperature. The syringes were 
mounted on an infusion syringe pump (Kd Scientific, model 200, USA) that controls 
in a programmable manner the flow of each solution into the inlet channels. The 
lipid dispersion in ethanol flows through the center inlet channel, and the deionized 
B A 
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water flows through the two side inlet channels that hydrodynamically compressed 
the central stream. 
 The Flow Rate Ratio (FRR) is the ratio of the volumetric flow rate of the 
central stream to the total volumetric flow rate of the side streams. In the present 
study, for producing cationic liposomes, we used FRR of 10, lipid concentration in 
the dispersion of ethanol in the central stream of 25 mM and an average fluid flow 
velocity (Vf) of 143 mm/s, at room temperature. 
2.5. Preparation of DNA/CL complexes  
 We carried out the preparation of the complexes in the continuous 
microfluidic methods and in bulk mixing method. DNA/CL complexes obtained by 
both methods were prepared at cationic lipid/DNA molar charge rate (R+/−) of 6, 
once it was in the best range of DNA/LC molar charge ratio (R+/-) for in vitro 
transfection in HeLa cells [27]. In the microfluidic method, we compared two 
microfluidic flow focusing devices (Figure 1) to verify the geometries effects on 
physicochemical and biological properties of the complexes. The DNA and 
liposomal solutions were loaded into sterile 1 and 3 mL glass syringes, 
respectively. The syringes containing the DNA and the cationic liposomes were 
placed in two separate infusion syringe pumps (Kd Scientific, model 200, USA) 
which were programmable adjusted to the desired volumetric flow rate ratio 
between the DNA and CL. The DNA solution was injected in the central stream and 
hydrodynamically compressed by two liposomal streams, as illustrated in the inset 
of Figure 1. The FRR of the liposomal solution stream to the DNA solution stream 
in all experiments was 5. To control the temperature, a Peltier 
thermoelectric system (Watronix, Inc) was employed, the temperature was 
maintained at approximately 4 °C and the cooling platform was placed under the 
microfluidic devices. In the bulk mixing methods, the complexes were prepared by 
adding the appropriate amount of plasmid DNA to CL under vortex [25, 26].   
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2.7. Physicochemical characterization 
2.7.1. Average hydrodynamic diameter and Polydispersity 
 To measure the size distribution, polydispersity and the average 
hydrodynamic diameter of the complexes we employed the Dynamic Light 
Scattering (DLS) technique, using Zetasizer Nano ZS (Malvern) with a 
backscattering configuration with detection at a scattering angle of 173° with a 
He/Ne laser emitting at 633 nm and a 4.0 mW power source. The average 
hydrodynamic diameter, or Z-average size, was weighted by intensity of scattering 
in DLS. The size distribution is evaluated with the polydispersity index, which has a 
range from 0 up to 1, indicating more and less homogeneous distribution of the 
particle size, respectively.  It is calculated from Cumulants analysis of the DLS 
measured intensity autocorrelation function. All the analyzed samples were diluted 
at a lipid concentration of ~0.2 mM before analysis. 
2.7.2. Zeta Potential Measurement 
 The zeta potential of the samples was measured by applying an electric field 
across the samples and the zeta potential value was obtained by measuring the 
velocity of the electrophoretic mobility of the particles using the technique of laser 
Doppler anemometry. The measurements were performed in triplicate for each 
sample at 25 °C, in water, using Malvern Zetasizer 3000 (Malvern) equipped with a 
standard 633 nm laser. The viscosity was assumed to be the same as that of 
water. 
2.7.3. Morphology  
 The DNA/CL complexes obtained by two microfluidic devices were observed 
to verify the morphology by means of Transmission Electron Microscopy (TEM) 
and the negative staining method. Approximately 5 L of each sample were put on 
a copper grid coated with a carbon film. The excess of the liquid was removed with 
blotting paper. Negative staining was done with a 2% solution of ammonium 
molybdate for ~10 s and then blotted dry. The electron microscopic model was 
LEO 906E (Zeiss, Germany) at 80 kV, together the camera MEGA VIEW III 
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/Olympus and the software ITEM E 23082007/ Olympus Soft Imaging Solutions 
GmbH. 
2.7.4. Gel retardation assay  
 We used agarose gel electrophoresis technique to verify whether the 
DNA/CL complexes by bulk and microfluidic methods are able to compact the DNA 
into the liposomal structures. The DNA/CL  complexes at molar charge ratio of 6 
(containing 1 g of DNA) were electrophoresed in 0.8% agarose gel in 40mM 
TRIS-acetate buffer solution, 1mM EDTA (TAE 1X) at 60V during ~3 h and stained 
for 30 min in a 0.5 g/mL ethidium bromide solution. The location of the DNA was 
then visualized and photographed using an ultraviolet image acquisition system. 
2.7.5. Plasmid DNA accessibility 
 We evaluated the plasmid DNA accessibility to the fluorescence probe using 
the double-stranded DNA quantification kit (Quant-iT PicoGreen dsDNA assay, 
Invitrogen) in accordance with manufacturer’s instructions. Briefly, the working 
solution was prepared by diluting the Pico Green stock solution 200 times in TE 
buffer (10 mM Tris–HCl/1 mM EDTA, pH 7.5). One hundred microliters of the 
working solution was added to the same volume of complexes and then incubated 
for 3 min. The intensity of the fluorescence was measured using a plate fluorimeter 
(Gemini XS, Molecular Device) using excitation and emission wavelengths of 485 
and 525 nm, respectively. The fluorescence intensity was expressed as relative 
fluorescence intensity using free DNA as the positive control and taken as 100% 
fluorescence level. 
2.8. Culture and transfection of mammalian cells  
 The biological evaluation of the complexes obtained by the different 
methods was assessed by the in vitro transfection in human epithelial carcinoma 
(HeLa) cells. Cells were cultivated in F-12 (Ham) nutrient mixture (Gibco, UK), 
containing 10% (v/v) fetal bovine serum (FBS) (Gibco, UK) and supplemented with  
non-essential amino acids (Gibco, UK), gentamicin (Gibco, UK), sodium pyruvate 
(Gibco, UK), and  antibiotic–antimycotic (Gibco, UK). Cultures were incubated 
Capítulo 5 
122 
 
under 37 °C and 5% CO2 for 24 h in a humid atmosphere and allowed to grow near 
confluency and harvested with trypsin. After reaching confluence, cells were 
seeded into 24-well culture plates (5104 cells per well). The cells were then 
incubated for 48 h and transfected with 0.8 g of pVAX-Luc per well and the 
medium was replaced 6 h after the transfection to remove plasmids not internalized 
by cells. The medium was removed, the cells were washed using PBS, lysed, and 
the luciferase activity was determined according to the Promega Luciferase Assay 
protocol. The Relative Light Units (RLUs) were measured with chemiluminometer 
(Lumat LB9507, EG&G Berthold, Germany). The total protein was measured 
according to a BCA protein assay kit (Pierce) and luciferase activity was expressed 
as RLU/mg protein. 
2.9. Statistical analysis 
 The data were expressed as the mean of triplicates ± standard deviation 
(SD). When indicated, the standard deviation was obtained based on the 
Propagation Uncertainties Theory [43]. Statistical significance was determined 
using two-tailed Student’s t-test with the level of confidence being p<0.05. 
3. Results and Discussion 
 The primary motivation for our work was the investigation of continuous 
process in microfluidic devices for production of pDNA/CL complexes for gene 
delivery and vaccine therapy. We used two different microfluidic devices: one with 
a simple straight channel with a hydrodynamic focusing, as showed in Figure 1A 
(SMD), and another with a patterned channel (Figure 1B, PMD), which has 
contraction and expansion regions through regular blocks in the microchannel 
walls, involving the generation of turbulence or eddies and the mixing occurs 
through chaotic advection [44, 45]. As a comparison, we formed the complexes in 
the bulk mixing method.  
Considering the comparative study, we investigated the previous pDNA/CL 
bulk complexation using vortexing, but at the same molar charge ratio (R+/-) of 6 
between cationic charges from the cationic lipid and the negative charges from the 
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phosphate in the DNA molecule.  This R+/- was previous identified in the best range 
for in vitro HeLa transfection of EPC/DOTAP/DOPE liposomes complexed with 
DNA, using bulk method [27]. Since the pDNA/CL charge molar proportion was 
previous established, the volumetric flow ratio between DNA and CL streams were 
constant. The investigated parameters were the complexation temperature and the 
total fluid flow velocity. 
Additionally, since R+/- used was 6, it means that there is an excess of 
cationic charge in comparison to negative charge from DNA, we introduced the 
pDNA stream at the central inlet in both devices and it is hydrodynamic 
compressed by the two aqueous streams (Figure 1). This central inlet of pDNA 
stream was evaluated before by Jellema et al [38] and Otten et al. [35]. 
3.1. Effect of temperature control on complexation process between CLs and 
plasmid DNA in microfluidic devices 
 Due to the spontaneous, fast and irreversible electrostatic interactions 
between positively charged lipids and negatively charged plasmid DNA, we 
hypothesized that the processing temperature in the microchannel can influence 
the process of complexation and affect the formation of the complexes. Thereby, 
we assessed the effect of temperature (at 25oC and 4 °C) on particle size and 
polydispersity of the complexes (Figure 2).  
 As observed in Figure 2, the temperature control was significant only for the 
simple microfluidic device, on both investigated parameters (particle size and 
polydispersity index). No statistical difference was observed when we changed the 
process temperature for production of DNA/CL complexes using the BM and the 
PMD, which the last one has a longer microchannel and thus the complexes go 
through a longer mixing time through the microfluidic device. We can separate the 
explored complexation methods in two groups: (i) group I with high average 
diameter and polydispersity (BM at 4/25oC and SMD at 25oC) and (ii) group II with 
the low average diameter and polydispersity (SMD at 4oC and PMD 4/25oC). 
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Figure 2. Effect of temperature on (A) Particle size and (B) Polydispersity Index of the 
complexation process between CLs and plasmid DNA for different methods. Average fluid 
flow velocity of the microfluidic devices of 140 mm/s. The flow rate ratio was maintained at 
5. Error bars correspond to SD of three independent experiments. *Statistically different (p 
< 0.05) when compared between the pairs. **Statistically different (p < 0.05) when 
compared to the bulk mixing method at 4 or 25°C. 
  
The influence of the temperature during the complexation process between 
DNA and cationic liposomes was reported by Wasan and co-workers [29] using a 
repeated slow mixing pipetting of equivolumetric suspensions and usually for a 
total volume of less than 1 mL. These authors showed that, by equilibrating the 
solutions of CL and DNA prior to mixing to temperatures of about 2 °C to about 7 
°C, size control of the formed complexes was achieved. Considering pipetting 
mixing as an inefficient and usually poor reproducible mixing method, probably the 
B 
A 
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complexation temperature begins to exert great influence on the size of the 
aggregates, since it probably decreases the velocity of complexation reaction.  
As well as pipetting mixing, vortex system mixing method is generally 
disadvantageous, since in this circular flow method the liquid moves in a streamline 
fashion and there is little mixing between fluid at different heights in the tank [46]. 
As consequence, the average diameter and polydispersity index of complexes 
obtained at 4 and 25oC were high and classified in the group I. Besides the high 
level of average diameter, we could not identify differences in process temperature 
for BM, probably due to the low lipid and DNA concentration. In addition, vortex is a 
laboratorial procedure that cannot be used in case of increasing the volumetric 
production. 
Similar temperature behavior described by Wasan and co-workers [29] was 
identified for the SMD. Since the mixture in the hydrodynamic focusing depends 
basically on diffusive gradients and convective flow, the temperature has to be 
decreased for proper size control. When the DNA/CL complexation was carried out 
in the PMD, there is an enhancement in mixing performance as previous described 
in simulation studies, based on the Computational Fluid Dynamics using numerical 
methods and algorithms to investigate the behavior of the fluid flow throughout 
similar microchannels [44, 45]. In this last case, the channel geometry with 
obstacles allows the formation of swirling vortexes or eddies, increasing the 
contact area between the two fluids and reducing the diffusion distance to achieve 
uniform concentration. Thus, with higher mixing quality, the temperature exerts no 
significant influence as identified in Figure 2.  
According to these results, the complexation between CL and DNA depends 
on a balance between mixing pattern and temperature. Considering the microfluidic 
devices, cases of poor mixing requires decrease in the process temperature in the 
same manner as previously described by Wasan et al., [29], as identified in the 
SMD. However, when the PMD is used, the mixing is enhanced and there is no 
necessity in temperature control. As consequence this last process becomes more 
robust than the first one.  
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3.2. Effect of Average Fluid Flow Velocity (Vf) on Complexes Size Distribution 
 Considering the differences on the process with the temperature control for 
simple and patterned microfluidic devices, we investigated the effects of the 
average fluid flow velocity (Vf), or total volumetric flow rate, on complex size and 
polydispersity over five different conditions. In this case, all experiments were 
carried out at 4oC. As can be seen in Figure 3, the particle size and the 
polydispersity remain approximately unaffected by the fluid flow velocity at the 
studied ranges. Previous reports have also indicated that the Vf has little impact on 
particle formation [19-21, 42, 47, 48]. This event suggests that the fluid residence 
time in the microchannel for forming the complexes was sufficient even for higher 
Vf. The explored ranges of Vf had residence times of 0.3 and 0.06 s, for maximum 
and minimum Vf, respectively.  
 
Figure 3. Particle size and polydispersity index of the complexes formed in simple and 
patterned microfluidic devices as function of mean fluid flow velocity in the center outlet 
channel (the combined flow velocities of all inlets) at 4oC. The flow rate ratio was 
maintained at 5. The error bars represent the standard error of independent triplicates. 
  
A 
B 
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 The fluid flow velocity is a microfluidic parameter directly proportional to the 
Reynolds number (Re). Re is generally considered the most important 
dimensionless parameter in the field of fluid mechanics, which represents the ratio 
of inertial forces to viscous forces and consequently quantifies the influence of 
these forces for a given flow conditions [49, 50]. We evaluated the Reynolds 
number (Re) (Equation 1), that is a dimensionless parameter which represents the 
ratio of the inertial forces to viscous forces [49]. 
        (Equation 1) 
where Dh is the hydraulic diameter,  is the fluid density and µ is the dynamic 
viscosity. The Re values are presented in Table 1. Despite having distinct 
dimensions when compared to macroscale equipments, the transition from laminar 
to turbulent flow in microchannels is similar. It is well known that the onset of this 
transition at the macroscale has a minimum lower critical Reynolds number 
between 1,800 and 2,300 and so have the channels with diameters between 50 
and 247 m [51]. Thus, as summarized in Table 1, in our microfluidic system, the 
variation in Re did not undergo the transition range of the characteristic flow, i. e., 
in all studied ranges of Vf the fluid flow is in laminar flow conditions. 
 In addition, the influence of the walls in microfluidic devices has a strong 
impact on the particle motion [52], and as a consequence, the wall shear rate (S). 
The wall shear rate between parallel plates is given by the following equation: 
         (Equation 2) 
where QT is the total volumetric flow rate in terms of mL/min, W is the microchannel 
width in terms of cm, and d is the half-microchannel depth in terms of cm [49]. The 
shear rate is presented in Table 1. Considering the patterned microfluidic device 
have two distinct regions (one with 140 and a second one with 70 m), we 
calculated the maximum and minimum shear rate. We can observe that the PMD 
has regions with double shear rate than SMD. This is an additional information that 
can also justify the better mixing and no influence on temperature for DNA/CL 
complexes production. 
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 Table 1.  Flow properties of continuous formation of DNA/CL complexes in 
simple and patterned microfluidic devices at Vf of 140 mm/s and temperature 
control. The maximum and minimum for the patterned microfluidic device indicates 
the flow through compression regions (in the blocks) and expansion regions.  
Microfluidic Device 
Reynolds 
Number 
Wall Shear 
Rate (104 s-1) 
 Simple 16.3 0.9 ± 0.1(i) 
Patterned 
Minimum 16.3 0.9 ± 0.1(i) 
Maximum 23.5 1.7 ± 0.3(i) 
 (i) Standard deviation based on the Propagation 
Uncertainties Theory [43]. 
3.3. Physicochemical properties and Morphology of DNA/CL complexes 
 To characterize the differences of DNA/CL complexes produced by simple 
and patterned microfluidic devices, we selected the process condition of Vf of 140 
mm/s, FRR 5 and process temperature of 4ºC. The DNA/CL complexes were 
obtained and characterized according particle size, polydispersity index and zeta 
potential (Table 2). The bulk method was evaluated for comparison. 
Table 2.  Physicochemical properties of DNA/CL complexes obtained by the bulk 
mixing and microfluidic methods with Vf of 140 mm/s and at 4 °C. 
 Complexation method 
 
Bulk Mixing 
Simple 
Microfluidic Device 
Patterned 
Microfluidic Device 
Particle Size(i) (nm) 141.4 ± 7.2 119.8 ± 1.6* 118.8 ± 7.9* 
Polydispersity Index 0.29 ± 0.03 0.22 ± 0.02* 0.23 ± 0.03 
Zeta Potential (mV) 52.7 ± 0.7 53.6 ± 1.7 64.5 ± 1.4* 
Results represent mean ± SD of three independent experiments 
(i) Intensity-weighted averaged hydrodynamic diameter. 
* Statistically different (p<0.05) when compared to the bulk mixing method  
 
 DNA/CL complexes produced by both microfluidic device and also by the 
bulk method presented positive zeta potential in water as summarized Table 2, 
which indicates the complexes produced by both devices and by bulk method are 
cationic and considered suitable for in vitro transfection experiments. The 
difference in zeta potential is probably due to the modifications of physicochemical 
properties when shear is applied due the complexation process between DNA and 
CL [53-55], such as zeta potential [55]. Thus, the difference in Zeta Potential is 
probably due to the different shear rates applied, and as observed by Balbino et al. 
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[42], the higher shear rates applied the higher zeta potential values are for 
production of cationic liposomes. 
 Morphological characterization of the complexes formed by the microfluidic 
complexation method, performed by transmission electron microscopy (TEM) using 
negative staining technique, is presented in Figure 4. Complexes formed by both 
microfluidic devices had relatively small and homogeneous particle sizes, which is 
in good agreement with the DLS results (Figure 3).  
   
Figure 4. TEM images of DNA/cationic liposomes complexes produced by (A) simple 
microfluidic device and (B) patterned microfluidic device at flow rate ratio of 5, at 4 ºC and 
Vf of 140 mm/s. Scale bars indicate 500 nm. 
 The complexation process between DNA and cationic liposomes for the 
different methods were evaluated by gel retardation assay (Figure 5). All samples 
were prepared at the molar charge ratio of 6. It is possible to see in lane 1 that the 
free pDNA migrated out of the well towards the cathode and presented two bands: 
the less-intense one is considered to be the DNA non-super-coiled, and the most 
intense band with high-mobility represents the DNA super-coiled form. As no 
running band of pDNA is observed in lanes 2 to 4, we can conclude that all the 
complexation methods were able to complex completely DNA into the cationic 
liposomes, indicating that all processes did not affect the stability and intactness of 
the structures. Such results are in good agreement with Balbino et al. [27], who 
studied the same lipid composition with extruded cationic liposomes produced by 
thin film method and complexed with plasmid pVAX-Luc also in bulk method. This 
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comparison shows that these methods for CL production and complexation with 
DNA did not alter the capacity in carring the DNA. 
 
Figure 5. Electrophoretic mobility retardation assay of DNA complexed with cationic 
liposomes in different methods. Lanes: (1) free DNA; complexation processes: (2) bulk 
mixing; (3) simple microfluidic device; and (4) patterned microfluidic device. Average fuid 
flow velocity of the microfluidic devices of 140 mm/s, at 4oC and FRR 5. 
To increase knowledge about the influence of the microfluidic device in the 
formation of DNA/CL complexes we evaluate the DNA accessibility to fluorescent 
probe (Figure 6).  The fluorescent probe specifically binds to double-strand DNA, 
and its fluorescence increases proportionality to the quantity of non-electrostatically 
bound DNA into the liposomal structures [56]. The fluorescent probe can strongly 
interact not only to highly polymeric DNA but also to very small amounts.  
We can observe that DNA/CL complexes produced by bulk and simple 
microfluidic mixing methods presented similar relative fluorescence of 25.2 ± 1.1 
and 24.5 ± 5.0%, respectively. However, when we used the patterned microfluidic 
device the relative fluorescence was decreased in 44% (Figure 6). Considering we 
processed the DNA/CL at the same conditions and all DNA is incorporated into the 
cationic liposomes (Figure 5), the lower relative fluorescence for patterned 
microfluidic device indicates that lower quantity of non-electrostatically bound DNA 
into the liposomal structures.  This pointed out that the patterned microfluidic 
device can increase the association between the cationic liposomes and 
electrostatically bound DNA, modifying the structural organization of the nucleic 
acid into the liposomal structures. The higher shear and intense mixing applied in 
the patterned microfluidic device are probably the reasons for different structural 
DNA organization into the liposomes. 
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Figure 6. Relative fluorescence obtained by the probe in ultra pure water. Results with 
free DNA used as control for complexes DNA/cationic liposomes formed by three different 
methods: bulk, in the simple and in the patterned microfluidic devices. The operational 
conditions of the microfluidic process were average fuid flow velocity of 140 mm/s at 4°C 
and FRR 5. Error bars correspond to SD of three independent experiments (n = 3). * p < 
0.05 was considered statistically different when compared to other samples. 
 Differences in relative fluorescence were previously reported using 
DOTAP/DOPE and dehydrated-hydrated vesicles (DRV-EPC/DOTAP/DOPE). 
DOTAP/DOPE liposomes presented lower relative fluorescence than DRV-
EPC/DOTAP/DOPE [24]. In this reported case the lipid composition and probably 
the production method influenced on the quantity of non-electrostatically bound 
DNA into the liposomal structures. DNA-DOTAP/DOPE complexes presented 10% 
of relative fluorescence. In our case, the patterned microfluidic device presented 
relative fluorescence of 13.8 ± 1.1%, similar to DNA/DOTAP/DOPE complexes. As 
far as our knowledge, there is no related studies regarding differences in 
association with DNA and cationic liposomes using different microfluidic devices. 
3.6. In vitro HeLa transfection  
 The ability of pDNA/CL complexes obtained by BM and microfluidic methods 
to transfect HeLa cells in vitro was assessed (Figure 7) based on the previous 
physicochemical characterization and the established process conditions. 
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Figure 7. In vitro efficacy on HeLa cells transfection of DNA/CL complexes formed by bulk 
mixing and microfluidic methods. Activity was expressed in RLU/mg protein. The DNA/CL 
complexes were obtained appling average fuid flow velocity of the microfluidic devices of 
140 mm/s at 4°C and FRR of 5. Each data represents SD of three experiments, * p < 0.05 
was considered statistically different. NS, no significant (p < 0.05). 
 As observed in Figure 7, the biological efficacies of complexes obtained by 
both microfluidic devices were in vitro proved in human epithelial carcinoma cells 
(HeLa) cells. It is possible to see that free DNA did not transfect cells (or very low) 
and the complexes prepared by the PMD presented the lower transfection efficacy 
for the period of time the transfection was conducted. This is possibly due to the 
low DNA accessibility to the probe in the fluorescence study for these complexes. 
The high quantity of electrostatically bound DNA into the liposomal structures 
yielded in the PMD (Figure 6) probably influenced in the DNA release to cell, 
impairing the transfection process for the evaluated transfection time. The 
complexes formed in the simple microfluidic device yielded in similar transfection 
levels than the complexes formed in the bulk mixing complexation methods, 
suggesting the same DNA/lipid organization, in accordance to the same level of 
DNA accessibility to the probe in the fluorescence study.  
4. Conclusion 
 In conclusion, we have demonstrated the feasibility of employing two 
different microfluidic devices with hydrodynamic focusing in producing 
DNA/cationic liposomes complexes in nanometric scale. It was demonstrated that 
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the microfluidic complexation methods provided better control in particle size than 
the bulk mixing complexation method. The process temperature is a factor that 
must be investigated according the type of microfluidic device is employed. In 
addiciton, the use of different microdevices can control the mode of association 
between DNA and CL reflecting in different biological results and the higher the 
shear rate and better mixing the higher is the association between DNA and CLs. 
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____________________________________________________________________ 
CAPÍTULO 6 – CONCLUSÕES GERAIS 
____________________________________________________________________ 
 
 Com o presente trabalho, que, prioritariamente, visou o desenvolvimento de 
processo microfluídico para incorporação de DNA plasmideal em lipossomas 
catiônicos destinados à terapia e à vacinação gênica, pôde-se concluir que: 
 Os complexos formados por DNA plasmideal e por lipossomas catiônicos 
constituídos de EPC/DOTAP/DOPE são viáveis para aplicações in vitro 
quando produzidos com controle de tamanho e polidispersidade (processo 
“bulk”); 
 A razão molar de cargas R+/- entre 3 e 6 apresentaram melhores resultados 
(significativamente iguais) para transfecções em células humanas do tipo 
HeLa, além de não apresentarem níveis de citotoxicidade às células; 
 As propriedades físico-químicas e estruturais dos complexos 
pDNA/lipossomas catiônicos se correlacionaram com o fenômeno de 
transfecção em células HeLa. Foi possível concluir que, conforme há um 
aumento da proporção de DNA nos complexos com lipossomas catiônicos, 
há um aumento na fração de nanopartículas com duplas bicamadas 
fosfolipídicas. Esse aumento ocorre até próximo à região de isoneutralidade 
de cargas, sendo que, nesse ponto, também se verificou com os estudos de 
SAXS a presença de uma população de complexos com uma média de 
cinco bicamadas; 
 Foi possível produzir lipossomas catiônicos unilamelares em microcanais 
utilizando a focalização hidrodinâmica em altas concentrações com 
tamanho e polidisperdidade controlados de aproximadamente 100 nm e 0,2, 
respectivamente. A viabilidade biológica dos lipossomas produzidos foi 
comprovada in vitro em células HeLa; 
Capítulo 6 
140 
 
 Com a utilização do dispositivo microfluídico com dupla focalização 
hidrodinâmica foi possível operar com velocidades superficiais de 
escoamento mais altas que com o dispositivo de focalização única.  Assim, 
foi possível aumentar a produtividade dos sistemas microfluídicos em até 
13 vezes em relação aos reportados na literatura. Dessa forma, os 
lipossomas produzidos atendem aos requisitos industriais para aplicações 
das formulações lipossomais; 
 Foi possível produzir complexos DNA/lipossomas catiônicos em dispositivos 
microfluídicos destinados à terapia e vacinação gênica. Os estudos 
mostraram a factibilidade desse processo para a formação de complexos 
com controle de tamanho e de polidispersidades já determinados 
inicialmente nesse estudo; 
 A utilização de diferentes dispositivos mostrou que é possível se obter 
complexos entre DNA e lipossomas catiônicos com características 
diferentes. Os ensaios de acessibilidade à sonda de fluorescência ao DNA 
indicaram diferença na associação deste com as estruturas lipossomais, o 
que refletiu em diferentes níveis de transfecção para os complexos 
produzidos em ambos dispositivos. 
 Concluiu-se que a organização do DNA aos lipossomas catiônicos 
formados no dispositivo microfluídico com blocos nas paredes 
possivelmente interferiu na liberação do DNA no processo de transfecção 
em células HeLa para o tempo estudado. 
De modo geral, pode-se concluir que os sistemas microfluídicos 
empregados para a produção de lipossomas catiônicos e também para formação 
dos complexos DNA/lipossomas catiônicos em modo contínuo apresentaram-se 
promissores para aplicações em terapia e vacinação gênica. 
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____________________________________________________________________ 
CAPÍTULO 7 – SUGESTÕES PARA TRABALHOS FUTUROS 
____________________________________________________________________ 
 
 Para a continuação de pesquisas futuras no que tange ao desenvolvimento 
de processos microfluídicos de formulações lipossomais destinadas à terapia e à 
vacinação gênica, sugere-se o seguinte: 
 Estudar a cinética de transfecção in vitro para os lipossomas catiônicos 
constituídos pelos lipídeos EPC, DOTAP e DOPE. 
 Explorar o dispositivo de focalização dupla para a produção de outros tipos 
de partículas. Adicionalmente, fazer um estudo através de Fluidodinâmica 
computacional quanto ao comportamento hidrodinâmico na dupla 
focalização. 
 Desenvolver dispositivos com focalizações hidrodinâmicas múltiplas e 
estudar seu comportamento frente ao aumento do número de focalizações. 
 Conduzir experimentos de complexação entre lipossomas catiônicos e DNA 
nos dispositivos microfluídicos em concentrações mais altas (lipossomas 
produzidos pelo método “bulk”), viabilizando análises de SAXS que 
detalhem a modificação estrutural causada pela diferente forma de 
empacotamento do DNA obtida em cada dispositivo. 
 Estudar a influência da razão molar de cargas na complexação em 
microdispositivos. Também com o emprego de dispositivos com outras 
geometrias. 
 Avaliar a potencialidade da formação de outros complexos em dispositivos 
microfluídicos e sua associação com outros materiais. 
 
